Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2011);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;10.583;Q1;193;18;59;2518;1403;59;23.94;139.89;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;10.386;Q1;210;33;58;10674;1300;54;22.78;323.45;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;4700152457;Nano Today;journal;17480132;6.99;Q1;119;66;138;4358;1562;105;13.88;66.03;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
4;20425;Nature Reviews Drug Discovery;journal;14741776;6.281;Q1;289;242;621;6770;6523;462;13.33;27.98;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;5.422;Q1;201;91;238;6986;2700;223;12.27;76.77;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;12611;Drug Resistance Updates;journal;13687646, 15322084;4.917;Q1;100;27;51;3149;628;50;10.88;116.63;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X;4.88;Q1;278;116;398;14815;5933;348;13.26;127.72;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
8;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;4.19;Q1;194;307;908;28141;6663;890;6.92;91.66;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;18017;Neuropsychopharmacology;journal;0893133X;4.15;Q1;204;273;850;18232;6833;788;8.54;66.78;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
10;12455;Molecular Therapy;journal;15250024, 15250016;3.46;Q1;158;278;811;10988;5372;690;7.73;39.53;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;21195;Pharmacology and Therapeutics;journal;01637258;3.411;Q1;180;103;290;18833;2912;286;9.74;182.84;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
12;26371;Natural Product Reports;journal;02650568, 14604752;3.285;Q1;157;85;216;15034;1923;207;9.37;176.87;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
13;19907;Medicinal Research Reviews;journal;01986325, 10981128;3.242;Q1;119;26;77;4735;791;73;10.4;182.12;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;20681;Current Opinion in Pharmacology;journal;14714892;3.23;Q1;120;110;340;5553;2503;309;7.95;50.48;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
15;21000196010;Topics in antiviral medicine;journal;21615853;3.076;Q1;37;21;54;544;293;54;5.37;25.90;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
16;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;2.943;Q1;58;0;5;0;48;5;0;0.00;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
17;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.882;Q1;166;207;498;7558;2355;454;4.78;36.51;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;23010;Journal of Controlled Release;journal;01683659;2.763;Q1;237;549;1029;17216;7095;943;6.5;31.36;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
19;4400151524;Particle and Fibre Toxicology;journal;17438977;2.76;Q1;83;35;91;1595;735;88;8.31;45.57;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
20;18148;Pain;journal;03043959;2.74;Q1;238;454;1126;18816;6300;874;6.79;41.44;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
21;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.523;Q1;232;935;2408;31417;12696;2241;5.46;33.60;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
22;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.518;Q1;186;236;844;9036;4354;821;5.33;38.29;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
23;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.513;Q1;127;122;410;5950;2040;385;4.97;48.77;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
24;5100155080;Neurotherapeutics;journal;19337213;2.457;Q1;100;68;176;6372;1297;164;7.06;93.71;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;130126;Molecular Pharmaceutics;journal;15438384, 15438392;2.351;Q1;110;258;535;12591;3282;512;5.59;48.80;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
26;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.341;Q1;172;571;1511;14557;7072;1157;6.12;25.49;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
27;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.295;Q1;161;304;868;12151;4943;859;5.34;39.97;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
28;20435;Neuropharmacology;journal;00283908;2.293;Q1;150;324;723;20594;3728;703;5.27;63.56;United Kingdom;Elsevier Ltd.;1962-ongoing;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
29;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.252;Q1;240;725;2475;33891;14281;2418;5.69;46.75;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
30;24749;Addiction Biology;journal;13556215, 13691600;2.171;Q1;70;63;133;3188;735;128;5.9;50.60;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
31;29311;Current Cancer Drug Targets;journal;15680096;2.137;Q1;85;94;218;8928;1008;204;4.83;94.98;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
32;23916;Environmental Pollution;journal;02697491, 18736424;2.041;Q1;194;493;1462;23090;6199;1427;4.22;46.84;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
33;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2.021;Q1;173;309;797;7909;3831;613;5.94;25.60;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
34;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;2.013;Q1;106;113;181;4788;1380;175;7.87;42.37;Netherlands;Elsevier BV;2005-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
35;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.011;Q1;110;445;754;19771;3888;710;5.24;44.43;United States;Public Library of Science;2007-ongoing;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
36;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.998;Q1;93;120;361;6803;1697;333;4.74;56.69;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
37;21782;Psychopharmacology;journal;00333158;1.994;Q1;181;415;1001;25028;4573;952;4.43;60.31;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
38;16836;BMC Chemical Biology;journal;14726769;1.979;Q1;19;2;17;74;73;17;4.07;37.00;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q1); Molecular Medicine (Q1)"
39;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.962;Q1;102;111;352;4992;1671;345;5.08;44.97;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
40;26380;Drug and Alcohol Dependence;journal;03768716;1.956;Q1;151;305;784;13671;3279;747;3.92;44.82;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
41;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.939;Q1;98;37;126;5091;658;112;5.9;137.59;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
42;21196;Drug Discovery Today;journal;13596446;1.928;Q1;157;140;443;8041;2975;407;7.11;57.44;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
43;25218;Toxicological Sciences;journal;10960929, 10966080;1.89;Q1;164;299;741;16521;3608;683;5;55.25;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
44;20063;Biochemical Pharmacology;journal;00062952;1.885;Q1;181;352;1106;20811;5839;998;5.81;59.12;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
45;20084;British Journal of Pharmacology;journal;00071188;1.868;Q1;190;476;1582;30182;7308;1479;4.14;63.41;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
46;20624;Clinical Pharmacokinetics;journal;03125963;1.861;Q1;150;64;177;3425;1118;161;6.59;53.52;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
47;144771;Clinical Trials;journal;17407753, 17407745;1.859;Q1;55;86;213;1835;488;174;2.62;21.34;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
48;21237;Drug Safety;journal;01145916;1.803;Q1;115;96;289;4277;1136;227;4.99;44.55;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
49;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1.799;Q1;138;210;710;8044;3668;700;4.92;38.30;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
50;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.787;Q1;209;422;1350;16052;5928;1317;4.16;38.04;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
51;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1.759;Q1;81;136;366;15616;1712;337;5.6;114.82;Germany;Springer Verlag;2005-ongoing;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
52;23488;Current Medicinal Chemistry;journal;09298673;1.699;Q1;158;432;806;53487;4496;795;5.49;123.81;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
53;19600166302;Current molecular pharmacology;journal;18744702;1.689;Q1;34;18;62;2266;306;62;5.44;125.89;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
54;84948;Expert Opinion on Drug Delivery;journal;17425247;1.689;Q1;88;111;267;11234;1464;260;5.54;101.21;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
55;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.678;Q1;191;284;834;13735;4131;776;4.95;48.36;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Molecular Medicine (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
56;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.673;Q1;64;69;138;4194;609;127;5.08;60.78;Germany;Springer Verlag;2006-ongoing;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
57;5400152706;Nanotoxicology;journal;17435390, 17435404;1.654;Q1;72;62;85;2635;461;80;5.76;42.50;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
58;15576;European Neuropsychopharmacology;journal;0924977X;1.625;Q1;100;99;321;5365;1417;315;4.21;54.19;Netherlands;Elsevier BV;1990-ongoing;"Biological Psychiatry (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
59;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.616;Q1;143;260;715;13648;2778;684;3.88;52.49;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
60;19617;Antiviral Research;journal;01663542;1.616;Q1;108;181;439;7940;2144;430;5.02;43.87;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q1)"
61;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.608;Q1;144;235;705;12058;3209;665;4.21;51.31;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
62;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.601;Q1;153;295;945;15369;4187;907;4.67;52.10;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
63;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.598;Q1;161;299;899;9442;3722;887;4.2;31.58;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
64;4000148019;AAPS Journal;journal;15507416;1.588;Q1;96;69;236;2379;1125;224;5.39;34.48;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
65;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1.575;Q1;78;113;326;10954;1228;320;4.19;96.94;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
66;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.565;Q1;75;0;212;0;969;196;5.01;0.00;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
67;25075;Ecotoxicology;journal;09639292, 15733017;1.542;Q1;81;208;383;10017;1422;379;2.59;48.16;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
68;21351;Expert Opinion on Investigational Drugs;journal;13543784;1.541;Q1;94;146;456;11044;2057;431;4.97;75.64;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
69;21790;Antiviral Therapy;journal;13596535;1.515;Q1;78;158;391;5441;1377;373;3.18;34.44;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
70;21165;PharmacoEconomics;journal;11707690;1.515;Q1;91;86;276;3908;898;221;3.33;45.44;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
71;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.494;Q1;78;49;136;2213;628;129;4.89;45.16;United Kingdom;Nature Publishing Group;2001-ongoing;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
72;22454;International Journal of Pharmaceutics;journal;03785173;1.493;Q1;190;685;1745;25257;7632;1722;3.97;36.87;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
73;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.49;Q1;81;71;191;2065;529;172;2.71;29.08;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
74;21169;Pharmacological Research;journal;10436618, 10961186;1.488;Q1;118;165;340;8777;1682;328;5.44;53.19;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
75;20051;BioDrugs;journal;11738804;1.486;Q1;60;48;114;2573;549;109;4.36;53.60;United Kingdom;Adis International Ltd.;1997-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
76;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.483;Q1;52;180;109;4642;363;107;3.39;25.79;United States;American Chemical Society;2010-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
77;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.475;Q1;60;0;224;0;828;212;3.97;0.00;United Kingdom;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
78;26512;Tetrahedron;journal;00404020;1.473;Q1;209;1207;3622;59949;12464;3567;3.41;49.67;United Kingdom;Elsevier Ltd.;1957-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
79;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.468;Q1;78;100;165;10725;654;145;4.38;107.25;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Neuroscience (miscellaneous) (Q2)"
80;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1.466;Q1;89;72;286;2918;1046;283;3.68;40.53;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
81;20664;Current Drug Targets;journal;13894501;1.461;Q1;92;194;407;21891;1561;367;4.02;112.84;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
82;18071;Neurotoxicity Research;journal;10298428;1.439;Q1;65;100;190;6370;706;186;3.82;63.70;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
83;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.437;Q1;59;84;117;6936;531;106;4.86;82.57;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Physiology (medical) (Q2)"
84;20679;Current Opinion in Investigational Drugs;journal;14724472;1.423;Q1;71;0;401;0;1492;373;3.89;0.00;United Kingdom;Current Drugs Ltd.;1994, 2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
85;20682;Current Pharmaceutical Design;journal;13816128;1.414;Q1;140;407;1065;48285;4535;959;4.65;118.64;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
86;23079;Journal of Pharmaceutical Sciences;journal;00223549;1.413;Q1;159;483;1205;19675;4440;1153;3.62;40.73;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
87;20783;Expert Review of Vaccines;journal;14760584;1.405;Q1;75;170;436;11738;1654;349;4.97;69.05;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
88;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.395;Q1;89;38;89;4163;448;85;5.23;109.55;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
89;23053;Journal of Natural Products;journal;01633864, 15206025;1.384;Q1;124;410;1196;12424;4043;1149;3.6;30.30;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
90;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.354;Q1;116;113;308;5277;789;299;2.25;46.70;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
91;12331;Current Topics in Medicinal Chemistry;journal;15680266;1.351;Q1;104;230;446;24674;1862;371;4.54;107.28;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
92;22072;Current Gene Therapy;journal;15665232;1.347;Q1;65;50;133;6077;658;123;4.28;121.54;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
93;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.341;Q1;82;114;258;10207;895;229;3.38;89.54;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
94;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1.337;Q1;114;293;892;18526;2779;666;3.86;63.23;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
95;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.326;Q1;70;24;60;3831;294;53;4.83;159.63;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
96;24763;Addictive Behaviors;journal;03064603;1.316;Q1;114;237;549;8304;1503;544;2.53;35.04;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
97;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.313;Q1;76;99;216;4812;691;214;2.97;48.61;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
98;13250;Expert Opinion on Biological Therapy;journal;14712598;1.312;Q1;75;143;415;11942;1648;404;4.35;83.51;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
99;14990;Current Neuropharmacology;journal;1570159X;1.309;Q1;58;94;88;7032;391;82;3.8;74.81;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2)"
100;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;1.285;Q1;68;44;145;1686;539;131;3.54;38.32;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q2)"
101;25219;Toxicology;journal;0300483X;1.273;Q1;143;217;745;10109;3035;707;4.26;46.59;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
102;4400151608;ChemMedChem;journal;18607187, 18607179;1.267;Q1;92;239;626;9505;2172;604;3.33;39.77;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
103;28792;Cancer Biology and Therapy;journal;15384047;1.263;Q1;101;258;1131;11395;2448;823;2.78;44.17;United States;Landes Bioscience;2002-ongoing;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
104;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;1.261;Q1;55;70;236;1568;444;149;3.07;22.40;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
105;21331;European Journal of Pharmaceutical Sciences;journal;09280987;1.242;Q1;119;193;493;7465;1892;481;3.77;38.68;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
106;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.228;Q1;30;19;60;562;132;54;3.03;29.58;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
107;18073;NeuroToxicology;journal;0161813X;1.225;Q1;102;121;382;6479;1396;363;3.45;53.55;Netherlands;Elsevier BV;1979-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
108;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.22;Q1;131;242;685;8653;2162;513;3.87;35.76;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
109;26514;Tetrahedron Letters;journal;00404039;1.217;Q1;159;1753;5259;60624;15573;5211;3;34.58;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
110;23015;Journal of Ethnopharmacology;journal;03788741;1.215;Q1;170;762;1344;30267;5376;1325;3.6;39.72;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
111;17067;Phytomedicine;journal;09447113;1.215;Q1;105;199;496;6550;1941;487;3.89;32.91;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
112;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1.214;Q1;82;43;163;2611;480;163;2.68;60.72;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
113;21167;Pharmacogenomics;journal;14622416;1.213;Q1;83;166;567;8344;2061;457;4.38;50.27;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
114;7700153108;International journal of nanomedicine;journal;11782013, 11769114;1.211;Q1;100;333;195;1217;885;193;2.94;3.65;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Bioengineering (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Biomaterials (Q2); Nanoscience and Nanotechnology (Q2)"
115;23109;Journal of Psychopharmacology;journal;02698811;1.194;Q1;106;174;512;10250;1616;445;3.45;58.91;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
116;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1.191;Q1;114;492;1296;13994;4568;1278;3.4;28.44;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1)"
117;22983;Journal of Clinical Pharmacology;journal;00912700;1.181;Q1;106;178;410;5567;1414;386;3.27;31.28;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
118;19034;Microbial Drug Resistance;journal;10766294;1.163;Q1;62;81;129;2755;378;129;2.52;34.01;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2)"
119;15581;Current Pharmaceutical Biotechnology;journal;13892010;1.16;Q1;73;232;226;21146;798;205;3.33;91.15;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
120;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;1.15;Q1;61;31;129;1199;355;117;2.55;38.68;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pulmonary and Respiratory Medicine (Q1)"
121;16088;Journal of Nanobiotechnology;journal;14773155;1.142;Q1;57;57;54;2106;257;54;4.21;36.95;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
122;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1.138;Q1;126;271;746;16615;2306;738;2.89;61.31;United States;Elsevier Inc.;1973-ongoing;"Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2); Clinical Biochemistry (Q2)"
123;24028;Reproductive Toxicology;journal;08906238;1.138;Q1;99;143;367;6452;1336;344;3.69;45.12;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q1)
124;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.137;Q1;142;798;2688;30190;8743;2652;3.21;37.83;United Kingdom;Elsevier Ltd.;1993-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
125;25240;Toxicology Letters;journal;03784274;1.133;Q1;129;292;786;12117;2875;755;3.45;41.50;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
126;21353;Expert Opinion on Therapeutic Patents;journal;13543776;1.129;Q1;61;112;304;9333;879;293;3.89;83.33;United Kingdom;Taylor & Francis;1991-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
127;145164;Human Genomics;journal;14739542, 14797364;1.126;Q1;49;37;85;1905;255;71;3.75;51.49;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
128;25096;Food and Chemical Toxicology;journal;02786915;1.124;Q1;149;503;1581;21072;5767;1535;3.61;41.89;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
129;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.122;Q1;133;1540;4353;40442;12284;4276;2.81;26.26;United Kingdom;Elsevier Ltd.;1991-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
130;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;1.116;Q1;69;11;36;2405;149;36;3.43;218.64;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
131;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;1.1;Q1;2;0;11;0;3;10;0;0.00;Netherlands;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
132;18966;Mutagenesis;journal;02678357, 14643804;1.092;Q1;82;104;188;5209;715;177;3.33;50.09;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
133;24604;Archives of Toxicology;journal;14320738, 03405761;1.084;Q1;96;163;315;8313;1286;269;4.78;51.00;Germany;Springer Verlag;1972-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
134;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1.071;Q1;100;360;791;11378;2501;769;3.1;31.61;Germany;Springer Verlag;1978-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
135;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.071;Q1;61;49;107;1963;334;106;3.15;40.06;United States;Mary Ann Liebert Inc.;2011-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
136;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.066;Q2;89;120;289;4362;847;263;3.56;36.35;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q2)"
137;25125;Journal of Analytical Toxicology;journal;01464760;1.066;Q1;69;98;302;2390;654;282;2.26;24.39;United States;Perston Publications, Inc.;1977-ongoing;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Environmental Chemistry (Q2)"
138;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.059;Q2;98;145;515;6474;1165;506;2.19;44.65;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q2)"
139;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;1.059;Q2;99;103;387;5411;1186;382;2.99;52.53;Netherlands;Elsevier BV;2000-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
140;19427;Advances in Pharmacology;book series;10543589;1.058;Q1;68;30;72;4440;194;52;4.39;148.00;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
141;21333;European Journal of Pharmacology;journal;00142999;1.058;Q1;167;816;2084;35237;6646;2067;2.92;43.18;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q1)
142;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.047;Q1;99;190;480;5553;1457;412;3.31;29.23;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
143;17464;European Journal of Medicinal Chemistry;journal;02235234;1.043;Q1;135;675;1677;26078;6569;1665;3.84;38.63;Netherlands;Elsevier BV;1974-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Organic Chemistry (Q2)"
144;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;1.033;Q1;83;116;334;5545;899;329;2.44;47.80;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
145;4400151410;Human Vaccines;journal;15548600, 15548619;1.027;Q1;49;266;377;9869;927;279;3.27;37.10;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q2)"
146;24652;Chemico-Biological Interactions;journal;00092797;1.019;Q2;108;202;802;8642;2706;777;3.33;42.78;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
147;29712;Clinical Therapeutics;journal;01492918;1.019;Q1;123;195;808;7092;2420;709;3.07;36.37;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
148;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;1.018;Q1;72;123;370;11161;1488;365;3.56;90.74;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Toxicology (Q2)"
149;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.016;Q1;63;81;177;3439;451;145;3.34;42.46;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
150;20473;Life Sciences;journal;00243205;1.014;Q1;150;295;737;13495;2293;729;2.83;45.75;Netherlands;Elsevier BV;1962-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
151;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.997;Q1;36;33;68;4134;208;68;3.47;125.27;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)"
152;20663;Current Drug Metabolism;journal;13892002;0.993;Q1;97;98;276;10022;1388;256;5.56;102.27;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Pharmacology (Q1); Clinical Biochemistry (Q2)"
153;25109;Inhalation Toxicology;journal;08958378, 10917691;0.992;Q2;77;105;308;4631;741;291;1.71;44.10;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
154;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.991;Q2;88;140;376;5430;983;366;2.73;38.79;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
155;18075;Neurotoxicology and Teratology;journal;08920362;0.988;Q2;89;90;160;4937;557;154;3.51;54.86;Netherlands;Elsevier BV;1987-ongoing;"Toxicology (Q2); Cellular and Molecular Neuroscience (Q3); Developmental Neuroscience (Q3)"
156;17595;Journal of Biomolecular Screening;journal;10870571;0.987;Q1;69;132;336;3595;781;330;2.25;27.23;United States;Sage Science Press;1996-ongoing;"Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
157;144790;Marine Drugs;journal;16603397;0.983;Q1;84;171;218;9262;1005;215;4.51;54.16;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q1)
158;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;0.982;Q1;44;89;217;4852;487;200;3.11;54.52;United States;Springer New York LLC;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (clinical) (Q2); Molecular Medicine (Q2); Genetics (Q3)"
159;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.979;Q2;74;158;577;5620;1426;573;2.34;35.57;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
160;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.979;Q2;70;85;519;3789;1268;504;2.57;44.58;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
161;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.978;Q1;80;98;236;3654;702;220;2.77;37.29;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
162;130063;Pharmacological Reports;journal;17341140, 22995684;0.977;Q2;71;156;394;6619;1145;372;2.87;42.43;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
163;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.973;Q2;43;46;123;5660;500;123;3.95;123.04;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
164;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.972;Q2;42;61;116;4860;427;111;4.13;79.67;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
165;22477;Investigational New Drugs;journal;01676997, 15730646;0.969;Q2;80;179;259;5596;705;254;2.49;31.26;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Pharmacology (medical) (Q1); Oncology (Q2); Pharmacology (Q2)"
166;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.963;Q2;54;47;103;1368;230;97;2.22;29.11;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
167;19700194010;MedChemComm;journal;20402503, 20402511;0.962;Q1;44;171;48;6313;130;45;2.89;36.92;United Kingdom;Royal Society of Chemistry;2010-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
168;21455;Progress in Medicinal Chemistry;book series;00796468;0.962;Q2;33;6;26;836;53;15;3.18;139.33;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
169;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.961;Q2;36;28;84;2577;251;83;2;92.04;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Hematology (Q2); Pharmacology (Q2)"
170;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.957;Q1;89;95;227;4269;727;219;3.46;44.94;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
171;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0.951;Q2;67;46;142;2478;375;140;2.97;53.87;Netherlands;Elsevier BV;1996, 1998-ongoing;"Biochemistry (Q2); Pharmacology (Q2); Physiology (Q2); Cell Biology (Q3)"
172;24785;Alcohol;journal;07418329;0.95;Q2;74;74;200;3742;575;197;2.79;50.57;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
173;23155;Current Vascular Pharmacology;journal;15701611;0.944;Q2;54;74;173;7940;545;162;3.33;107.30;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
174;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.942;Q2;78;132;271;5178;541;269;1.94;39.23;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Computational Theory and Mathematics (Q2); Immunology (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)"
175;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;0.94;Q1;64;184;201;3538;797;195;4.4;19.23;United States;American Scientific Publishers;2007-ongoing;"Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Nanoscience and Nanotechnology (Q2)"
176;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.939;Q2;91;185;440;7716;1169;415;2.65;41.71;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
177;16948;Chirality;journal;1520636X, 08990042;0.932;Q2;73;145;400;5890;1058;393;2.53;40.62;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
178;16533;Phytochemical Analysis;journal;09580344, 10991565;0.931;Q2;63;76;219;1857;588;214;2.84;24.43;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Plant Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2)"
179;4700152848;PPAR Research;journal;16874757, 16874765;0.929;Q2;40;19;192;948;390;178;1.8;49.89;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2)"
180;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.928;Q1;44;117;159;4581;338;145;2.33;39.15;United Kingdom;John Wiley & Sons Ltd.;2009-ongoing;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Spectroscopy (Q2)"
181;14805;Steroids;journal;0039128X;0.925;Q2;95;215;479;8929;1514;465;3.17;41.53;Netherlands;Elsevier BV;1963-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
182;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.921;Q1;15;13;7;776;25;6;4.17;59.69;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
183;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.921;Q2;87;104;346;3198;1091;331;2.96;30.75;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
184;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.912;Q2;60;175;533;6383;1319;524;1.89;36.47;United States;Taylor and Francis;2008-ongoing;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
185;22319;Toxicon;journal;00410101;0.908;Q2;116;217;903;9582;2477;866;2.91;44.16;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
186;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0.906;Q2;33;80;96;1629;160;90;1.61;20.36;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
187;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.891;Q2;87;66;329;2607;919;319;2.92;39.50;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3)"
188;25214;Toxicologic Pathology;journal;15331601, 01926233;0.869;Q2;96;122;298;4815;744;265;2.6;39.47;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
189;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.865;Q1;35;89;274;1593;378;175;2.02;17.90;United States;Wiley-Blackwell;2008-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q2)"
190;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.865;Q2;90;146;423;6596;1045;383;2.86;45.18;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
191;29053;Molecular Diversity;journal;1573501X, 13811991;0.864;Q2;54;98;155;3755;455;147;3;38.32;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Information Systems (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
192;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0.855;Q2;79;108;367;10227;1078;363;2.85;94.69;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
193;14822;Xenobiotica;journal;00498254, 13665928;0.85;Q2;75;109;253;3962;646;248;1.94;36.35;United Kingdom;Taylor & Francis;1971-ongoing;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
194;22411;Inflammopharmacology;journal;09254692, 15685608;0.849;Q2;45;36;108;1754;322;102;2.63;48.72;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
195;25224;Toxicology in Vitro;journal;08872333;0.846;Q2;96;268;701;11245;2141;691;3.12;41.96;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
196;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.845;Q2;54;168;264;10362;494;195;2.53;61.68;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
197;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0.836;Q1;58;80;184;2751;420;161;2.55;34.39;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
198;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.832;Q2;78;172;437;5621;862;430;1.72;32.68;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
199;22432;International Immunopharmacology;journal;15675769;0.828;Q2;98;318;706;14732;2016;682;2.76;46.33;Netherlands;Elsevier BV;2001-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
200;4000150314;Chemical Biology and Drug Design;journal;17470277;0.824;-;71;168;381;5952;954;369;2.48;35.43;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q2); Molecular Medicine (Q3)"
201;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.82;Q2;76;93;289;4490;794;286;2.76;48.28;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
202;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.82;Q2;64;79;182;2620;444;176;2.41;33.16;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
203;22378;Vascular Pharmacology;journal;15371891;0.816;Q2;86;43;197;2068;493;191;2.32;48.09;Netherlands;Elsevier BV;2002-ongoing;"Pharmacology (Q2); Physiology (Q2); Molecular Medicine (Q3)"
204;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0.811;Q2;46;19;54;690;133;51;2.58;36.32;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q2)"
205;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0.805;Q2;80;127;434;5595;858;418;1.95;44.06;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
206;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0.802;Q2;80;139;428;5107;1153;416;2.29;36.74;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
207;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0.8;Q2;69;264;796;18824;2231;752;3.11;71.30;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
208;16573;Phytotherapy Research;journal;10991573, 0951418X;0.794;Q2;112;292;957;9036;2452;906;2.51;30.95;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
209;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.793;Q2;58;114;359;1879;436;319;1.37;16.48;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
210;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.785;Q2;78;98;341;3177;904;333;2.36;32.42;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
211;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;0.785;Q1;13;3;13;132;36;13;4.5;44.00;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
212;25898;Journal of Peptide Science;journal;10752617, 10991387;0.783;Q2;60;113;337;3995;642;327;1.86;35.35;United States;John Wiley & Sons Inc.;1995-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
213;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.778;Q2;49;48;127;4761;322;111;2.95;99.19;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
214;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.773;Q2;43;81;208;1606;244;180;1.6;19.83;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
215;25093;Environmental Toxicology;journal;15227278, 15204081;0.769;Q2;69;74;219;3285;470;216;2.11;44.39;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
216;22575;Cardiovascular Toxicology;journal;15307905;0.768;Q2;47;42;84;1892;192;81;2.48;45.05;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
217;20027;BMC Pharmacology;journal;14712210;0.766;Q2;38;15;50;501;134;50;2.71;33.40;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
218;20602;Clinical Neuropharmacology;journal;03625664;0.763;Q2;74;60;235;1414;615;207;2.99;23.57;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
219;4000148406;Clinical Toxicology;journal;15563650;0.761;Q2;85;152;496;3480;870;393;2.31;22.89;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
220;110172;Progress in Drug Research;book series;0071786X;0.76;Q1;38;15;20;1405;59;18;0;93.67;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
221;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.759;Q2;34;33;102;2040;226;96;1.62;61.82;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
222;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.756;Q2;95;140;635;5445;1295;596;2.16;38.89;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
223;5800173383;Current Clinical Pharmacology;journal;15748847;0.752;Q1;33;38;85;2420;194;83;2.34;63.68;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
224;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.75;Q2;54;59;130;2389;323;119;2.2;40.49;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
225;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0.745;Q1;25;19;43;2216;117;43;2.26;116.63;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
226;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.744;Q2;56;34;123;1705;381;122;3.45;50.15;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
227;130047;Current Drug Discovery Technologies;journal;15701638;0.74;Q2;38;38;96;2659;278;90;3.25;69.97;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q2)
228;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.737;Q1;37;42;111;1623;177;98;1.73;38.64;Netherlands;Elsevier BV;2005-ongoing;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
229;23942;Biomedical Chromatography;journal;10990801, 02693879;0.735;Q2;58;164;543;5271;1065;524;2.05;32.14;United States;John Wiley & Sons Inc.;1986-ongoing;"Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
230;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0.726;Q2;53;100;233;2770;433;224;1.94;27.70;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
231;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.725;Q2;77;112;341;4458;690;331;2.07;39.80;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
232;21194;Pharmacology;journal;00317012, 14230313;0.725;Q2;54;91;279;3003;573;249;1.97;33.00;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
233;26370;Molecules;journal;14203049;0.72;Q1;116;758;1286;30781;3495;1269;2.69;40.61;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
234;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.718;Q2;30;31;76;2410;170;74;2.33;77.74;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
235;21229;Drug News and Perspectives;journal;02140934;0.711;Q2;47;0;205;0;391;200;1.86;0.00;Spain;J.R. Prous;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
236;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.708;Q1;54;48;150;1791;352;150;2.46;37.31;United States;John Wiley & Sons Inc.;1979-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
237;21744;Planta Medica;journal;14390221, 00320943;0.707;Q1;103;287;749;9168;1774;720;2.2;31.94;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
238;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.703;Q1;104;331;1129;11011;2482;1097;2;33.27;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
239;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.701;Q2;78;201;564;8776;1220;556;2.07;43.66;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
240;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.7;Q2;39;57;131;3887;290;115;2.43;68.19;United States;Wiley-Blackwell;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
241;5800173401;Current Bioactive Compounds;journal;15734072;0.696;Q1;21;30;75;1859;122;66;1.95;61.97;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
242;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.695;Q2;58;41;116;1096;132;100;1.22;26.73;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
243;20570;Chemotherapy;journal;00093157, 14219794;0.694;Q2;49;50;181;1711;333;175;1.73;34.22;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
244;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0.694;Q1;107;190;476;7940;1079;466;2.14;41.79;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
245;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.691;Q1;52;123;267;3331;464;245;1.51;27.08;Germany;Springer Verlag;2010-ongoing;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q2)"
246;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.685;Q2;44;103;305;3032;636;294;1.81;29.44;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
247;19374;AAPS PharmSciTech;journal;15221059, 15309932;0.684;Q1;79;163;501;4301;1000;498;1.88;26.39;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
248;13248;Experimental and Toxicologic Pathology;journal;09402993;0.673;Q2;58;96;209;3612;536;205;2.78;37.63;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
249;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.672;Q2;29;17;64;2366;150;64;2.34;139.18;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
250;19443;American Journal of Health-System Pharmacy;journal;10792082;0.666;Q2;87;385;1210;5303;1486;691;2.2;13.77;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
251;6400153120;Chinese Medicine;journal;17498546;0.666;Q2;34;42;83;2193;215;74;2.81;52.21;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
252;21865;Fundamental and Clinical Pharmacology;journal;07673981;0.663;Q2;64;83;247;4020;549;233;2.09;48.43;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
253;22410;Inflammation Research;journal;1420908X, 10233830;0.661;Q2;82;140;423;5056;787;415;1.86;36.11;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
254;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.659;Q2;7;5;5;394;14;5;2.8;78.80;United Kingdom;Dove Medical Press Ltd;2010-ongoing;"Pharmacology (Q2); Biochemistry (Q3); Biophysics (Q3); Cell Biology (Q3)"
255;19984;Assay and Drug Development Technologies;journal;1540658X;0.656;Q2;52;101;281;2048;253;148;1.65;20.28;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3)"
256;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.655;Q1;26;27;66;1143;177;66;2.29;42.33;Spain;Elsevier Espana;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Agricultural and Biological Sciences (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
257;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.653;Q2;65;90;269;2831;526;252;2.05;31.46;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
258;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0.65;Q2;55;86;249;3784;514;233;2.24;44.00;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
259;15840;Journal of Antibiotics;journal;00218820;0.648;Q2;73;138;373;3692;618;350;1.76;26.75;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
260;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0.645;Q2;59;93;278;4945;591;250;2.06;53.17;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
261;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.64;Q2;63;266;809;4885;1102;800;1.22;18.36;Germany;Springer Verlag;1966-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
262;19700175230;Drug Design, Development and Therapy;journal;11778881;0.64;Q1;48;40;85;3421;226;81;3.07;85.53;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
263;23039;Journal of Liposome Research;journal;08982104, 15322394;0.64;Q1;44;39;84;1408;174;81;1.83;36.10;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q1)
264;20026;BMC Clinical Pharmacology;journal;14726904;0.639;Q2;35;23;46;722;132;46;2.88;31.39;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
265;16067;Reading Teacher;journal;00340561;0.639;Q2;44;91;234;1572;204;227;0.76;17.27;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
266;19600166320;Protein & Cell;journal;16748018, 1674800X;0.632;Q2;48;122;139;5417;185;129;1.43;44.40;Germany;Springer Verlag;2010-ongoing;"Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Cell Biology (Q3)"
267;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0.631;Q2;29;124;239;4997;560;239;2.45;40.30;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q2)
268;21100241608;Journal of Nanomedicine and Nanotechnology;journal;21577439;0.629;Q1;19;26;3;959;13;3;4.33;36.88;India;OMICS Publishing Group;2010-2014 (cancelled);"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2)"
269;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.627;Q2;79;261;749;6898;1167;746;1.61;26.43;United States;Wiley-Blackwell;1918-ongoing;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3)"
270;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.621;Q2;50;92;289;8715;570;283;2.26;94.73;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q2)
271;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.616;Q2;62;58;207;2521;408;206;2.08;43.47;United States;Wiley-Blackwell;1986-ongoing;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Molecular Medicine (Q3)"
272;19700188217;Bioanalysis;journal;17576180, 17576199;0.614;Q1;51;297;304;7348;668;269;2.48;24.74;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2)"
273;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.609;Q2;18;3;71;101;112;55;3.6;33.67;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
274;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0.604;Q2;36;31;61;973;124;59;1.61;31.39;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
275;19700185200;Journal of Natural Medicines;journal;18610293;0.604;Q1;37;103;241;2512;496;240;1.8;24.39;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
276;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.6;Q2;72;121;342;5263;638;338;1.77;43.50;Netherlands;Elsevier BV;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q3)"
277;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.599;Q1;54;91;226;2621;492;225;2.07;28.80;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2)"
278;130025;Current Drug Delivery;journal;15672018;0.599;Q1;54;68;149;4369;311;148;1.95;64.25;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q1)
279;24071;Metal-Based Drugs;journal;07930291, 16875486;0.597;Q2;33;1;23;34;78;22;2.71;34.00;Egypt;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Pharmacology (Q2); Toxicology (Q3)"
280;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.588;Q2;37;89;195;5033;404;159;2.84;56.55;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Clinical Biochemistry (Q3)"
281;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.587;Q1;69;43;125;1846;319;122;2.23;42.93;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
282;18077;Fitoterapia;journal;0367326X;0.585;Q2;90;205;445;6301;1031;443;2.15;30.74;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
283;19300156901;Dose-Response;journal;15593258;0.584;Q3;30;41;84;1725;175;82;2.23;42.07;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
284;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.583;Q2;54;96;376;2922;366;370;0.69;30.44;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
285;4700152612;Current Nanoscience;journal;15734137;0.582;Q2;37;135;171;6698;388;171;1.98;49.61;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
286;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;0.582;Q2;44;50;121;2158;263;118;2.25;43.16;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
287;20770;Drug Delivery;journal;10717544;0.58;Q2;52;80;170;3361;314;168;1.76;42.01;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
288;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.576;Q2;84;284;935;7166;1720;927;1.73;25.23;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
289;23412;Journal of AOAC International;journal;10603271;0.572;Q2;79;210;609;5595;844;592;1.26;26.64;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
290;24578;Mathematical Medicine and Biology;journal;14778599;0.561;Q2;40;17;53;653;88;53;2.03;38.41;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
291;19958;Archives of Pharmacal Research;journal;02536269;0.56;Q2;75;262;719;7792;1353;692;1.83;29.74;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
292;17500155003;Records of Natural Products;journal;13076167;0.554;Q2;24;44;59;1148;111;56;1.98;26.09;Turkey;ACG Publications;2009-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Plant Science (Q2); Organic Chemistry (Q3)"
293;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.552;Q3;33;38;100;1666;226;99;2.32;43.84;United Kingdom;BioMed Central;2006-ongoing;"Safety Research (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
294;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0.546;Q2;25;24;74;512;99;64;0.92;21.33;United States;Springer USA;2006-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
295;25864;Heterocycles;journal;03855414;0.544;Q2;61;228;1030;8242;1230;1016;1.2;36.15;Netherlands;Elsevier BV;1983, 1985-ongoing;"Pharmacology (Q2); Analytical Chemistry (Q3); Organic Chemistry (Q3)"
296;13671;Biologicals;journal;10958320, 10451056;0.543;Q2;51;72;229;1950;471;218;2.18;27.08;United States;Elsevier Inc.;1990-ongoing;"Applied Microbiology and Biotechnology (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Bioengineering (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
297;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.543;Q1;32;27;42;1056;86;41;0.96;39.11;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
298;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.54;Q1;43;7;232;273;557;230;2.67;39.00;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
299;20634;Journal of Texture Studies;journal;00224901;0.539;Q2;48;49;133;1847;150;133;0.93;37.69;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q2); Pharmaceutical Science (Q2)"
300;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.538;Q3;32;45;110;2180;195;107;1.36;48.44;United States;Taylor and Francis;2004-ongoing;"Immunology (Q3); Toxicology (Q3)"
301;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.538;Q2;70;84;212;3085;414;211;1.94;36.73;United Kingdom;Taylor & Francis;1984-ongoing;"Colloid and Surface Chemistry (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
302;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.533;Q2;42;40;121;1795;251;118;2.12;44.88;United Kingdom;Taylor & Francis;1993-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
303;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.531;Q2;24;32;74;2728;156;70;1.95;85.25;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
304;5800173386;Current Drug Safety;journal;15748863;0.526;Q2;31;59;126;2395;248;110;2.21;40.59;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
305;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.526;Q3;30;30;97;1699;150;93;1.61;56.63;Netherlands;Wageningen Academic Publishers;2009-ongoing;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
306;10900153302;Biomarker Insights;journal;11772719;0.525;Q2;24;18;60;571;120;60;2.78;31.72;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
307;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.516;Q3;53;49;135;1858;226;133;1.56;37.92;United States;John Wiley & Sons Inc.;1998-ongoing;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Molecular Medicine (Q3); Toxicology (Q3); Molecular Biology (Q4)"
308;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.504;Q2;22;15;78;807;103;70;1.29;53.80;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q2); Molecular Medicine (Q3)"
309;4700152769;Pharmacopeial Forum;journal;03634655;0.504;Q2;16;17;68;72;47;55;0.97;4.24;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Drug Guides (Q1); Pharmacy (Q1); Pharmacology (Q2)"
310;19700176055;F1000 Biology Reports;journal;17404118;0.502;Q1;27;26;88;1102;77;87;0.89;42.38;United Kingdom;Faculty of 1000 Ltd;2010-2013;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
311;16319;IEEE Transactions on Nanobioscience;journal;15361241;0.502;Q2;55;35;102;1068;267;100;2.18;30.51;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
312;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.497;Q2;37;19;96;1094;148;92;1.3;57.58;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Hematology (Q3); Molecular Medicine (Q3)"
313;19900192900;Molecular Informatics;journal;18681751, 18681743;0.496;Q3;60;88;290;3753;638;279;1.94;42.65;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3)"
314;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.487;Q2;45;230;420;5255;897;398;2.57;22.85;Italy;SAGE Publications Inc.;1989-ongoing;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
315;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.487;Q2;61;110;422;4132;700;417;1.64;37.56;United Kingdom;Taylor & Francis;1985-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
316;25171;Mycotoxin Research;journal;01787888;0.487;Q3;31;36;89;1264;125;83;1.59;35.11;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q2); Microbiology (Q3); Toxicology (Q3)"
317;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.485;Q2;50;71;169;2233;224;166;1.37;31.45;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
318;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;0.484;Q2;29;58;228;1647;327;219;1.62;28.40;India;Medknow Publications;2008-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
319;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0.477;Q2;30;8;55;261;64;51;1.17;32.63;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q2)
320;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.474;Q2;53;77;129;2762;226;123;1.38;35.87;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
321;21264;Drugs in R and D;journal;11745886;0.473;Q2;39;30;72;1169;135;69;1.15;38.97;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q2)
322;29947;Journal of Chemotherapy;journal;1120009X;0.462;Q3;45;83;315;2492;364;286;1.19;30.02;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
323;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.461;Q3;42;108;221;4095;347;216;1.69;37.92;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
324;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.459;Q3;50;27;111;1277;160;110;1.43;47.30;United States;Elsevier Inc.;1971-ongoing;"Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Biology (Q4)"
325;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0.459;Q3;41;72;180;1226;250;153;1.36;17.03;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
326;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.458;Q2;35;91;232;2336;434;231;1.86;25.67;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q2)
327;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.457;Q2;46;195;548;5233;491;543;0.76;26.84;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
328;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;0.457;Q3;40;27;87;2375;148;76;2.06;87.96;United Kingdom;SAGE Publications;2008-ongoing;"Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
329;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0.456;Q3;21;23;71;2464;148;71;2.2;107.13;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Immunology and Allergy (Q3)"
330;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.455;Q3;55;123;295;4308;417;275;1.37;35.02;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
331;19700175819;Patient Preference and Adherence;journal;1177889X;0.454;Q1;37;71;118;2594;183;117;1.75;36.54;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Social Sciences (miscellaneous) (Q2)"
332;26767;Altex;journal;1868596X, 18688551;0.453;Q3;45;36;94;1420;212;81;3.14;39.44;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
333;17700155034;Natural product communications;journal;15559475, 1934578X;0.451;Q3;35;427;1056;10656;1215;1037;1.35;24.96;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Plant Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
334;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.447;Q3;55;70;282;1225;303;217;1.2;17.50;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
335;20580;Journal of Food Biochemistry;journal;01458884;0.445;Q3;40;137;210;4401;203;204;0.97;32.12;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
336;15340;Developments in Biologicals;book series;14246074;0.444;Q3;35;0;123;0;149;121;0;0.00;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Biomaterials (Q3); Immunology (Q3); Pharmacology (Q3)"
337;19400158813;HIV Therapy;journal;17584329, 17584310;0.444;Q3;12;0;108;0;69;79;0.87;0.00;United Kingdom;Future Medicine Ltd.;2009-2010;"Dermatology (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Pharmacology (Q3); Virology (Q3)"
338;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.443;Q2;50;129;502;2843;810;502;1.17;22.04;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
339;25106;Human and Experimental Toxicology;journal;09603271;0.433;Q3;71;232;354;8535;549;316;1.64;36.79;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
340;27210;In Vivo;journal;0258851X;0.432;Q3;54;140;396;4068;542;386;1.45;29.06;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
341;17700156714;Pharmaceuticals;journal;14248247;0.431;Q2;44;90;199;7520;249;195;1.28;83.56;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2009-ongoing;"Pharmaceutical Science (Q2); Molecular Medicine (Q3)"
342;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.426;Q3;62;120;358;2600;487;335;1.21;21.67;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
343;130089;Toxin Reviews;journal;15569543, 15569551;0.426;Q3;38;13;63;800;90;60;1.45;61.54;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q3)
344;21256;Drugs of Today;journal;16993993, 16994019;0.422;Q3;46;73;257;4139;373;251;1.49;56.70;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
345;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.422;Q3;18;7;21;278;40;21;1.43;39.71;United Kingdom;BioMed Central;2003-2011;"Immunology (Q3); Pharmacology (Q3)"
346;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.417;Q2;22;37;71;1517;92;70;1.33;41.00;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
347;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.415;Q3;51;79;194;3029;279;180;1.53;38.34;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
348;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.415;Q3;52;114;214;4046;338;206;1.65;35.49;United States;SAGE Publications;1985-ongoing;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
349;18800156720;Dissolution Technologies;journal;1521298X;0.414;Q2;28;29;61;574;51;60;0.55;19.79;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
350;21207;Drug Discovery Today: Technologies;journal;17406749;0.414;Q3;41;18;64;601;89;56;1.69;33.39;Netherlands;Elsevier BV;2004-ongoing;"Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
351;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.412;Q1;52;272;510;3476;618;440;1.17;12.78;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
352;19398;Acta Pharmaceutica;journal;13300075;0.411;Q2;49;40;120;782;265;120;1.66;19.55;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
353;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996;0.405;Q2;29;100;139;2148;233;133;1.75;21.48;Nigeria;University of Benin;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
354;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.403;Q3;43;31;90;1364;118;90;1.24;44.00;United States;Begell House;1984-1990, 1992-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
355;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.396;Q2;35;170;511;2915;531;509;1.07;17.15;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
356;11200153563;Drug Metabolism Letters;journal;18723128;0.395;Q2;23;37;101;1126;124;100;0.98;30.43;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biochemistry (medical) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Clinical Biochemistry (Q3)"
357;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.395;Q3;21;45;85;1305;81;84;0.81;29.00;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
358;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.393;Q3;19;23;56;469;79;56;1.41;20.39;Bangladesh;Bangladesh Pharmacological Society;2009-ongoing;Pharmacology (Q3)
359;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0.391;Q1;16;17;62;377;83;62;1.37;22.18;United States;Science Publications;2007-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
360;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0.391;Q1;79;176;537;6211;782;521;1.35;35.29;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Cell Biology (Q4); Physiology (Q4)"
361;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.389;Q3;25;26;79;2513;104;79;1.24;96.65;United Arab Emirates;Bentham Science Publishers;2006-2015;"Pharmacology (medical) (Q2); Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3)"
362;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.387;Q1;45;127;386;4142;608;379;1.47;32.61;China;Zhejiang University Press;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
363;19700175061;Open Pharmacology Journal;journal;18741436;0.384;Q2;6;1;9;28;6;9;0.67;28.00;United Arab Emirates;Bentham Science Publishers;2009-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
364;22456;International Journal of Pharmacy Practice;journal;09617671;0.383;Q2;32;64;233;1558;155;211;0.77;24.34;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q3)"
365;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.381;Q3;30;39;123;1204;137;119;1.2;30.87;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
366;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.381;Q2;34;64;144;1844;201;143;1.37;28.81;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q2)
367;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.381;Q3;35;81;236;4028;274;224;1.25;49.73;United Kingdom;Taylor & Francis;1991-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
368;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.379;Q3;27;24;60;2263;105;60;1.76;94.29;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
369;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.375;Q3;26;0;70;0;62;59;0.82;0.00;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
370;25144;Journal of Health Science;journal;13475207, 13449702;0.373;Q3;42;70;329;2457;370;326;1.04;35.10;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
371;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.371;Q3;38;63;139;2035;186;139;1.3;32.30;United States;Marcel Dekker Inc.;1977-ongoing;"Medicine (miscellaneous) (Q2); Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
372;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.37;Q1;31;112;154;3081;155;142;0.91;27.51;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q3)"
373;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0.37;Q3;23;58;173;2134;172;173;1.05;36.79;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q3); Physiology (Q4)"
374;4700152603;Medicinal Chemistry;journal;15734064;0.37;Q3;39;81;182;3647;259;182;1.47;45.02;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
375;19383;Fluoride - Quarterly Reports;journal;00154725;0.367;Q3;41;34;125;791;111;115;0.85;23.26;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q2); Dentistry (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
376;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.367;Q3;33;0;36;0;44;31;0;0.00;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3)"
377;21192;Drug Development Research;journal;02724391, 10982299;0.366;Q3;54;83;175;5296;196;160;1.36;63.81;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
378;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences;journal;09751491;0.365;Q2;37;573;389;13596;489;386;1.27;23.73;India;International Journal of Pharmacy and Pharmaceutical Sciences;2009-2016 (cancelled);"Pharmaceutical Science (Q2); Pharmacology (Q3)"
379;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.364;Q3;21;0;68;0;71;65;0.83;0.00;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3)"
380;144963;Drug Discovery Today: Disease Models;journal;17406757;0.364;Q3;23;24;80;1114;72;68;0.69;46.42;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
381;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.364;Q2;53;178;517;6266;602;506;1.1;35.20;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
382;19600156803;Journal of Medicinal Plant Research;journal;19960875;0.363;Q2;47;930;528;28043;832;522;1.59;30.15;Nigeria;Academic Journals;2009-2011;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
383;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.359;Q3;40;123;512;4341;432;492;0.83;35.29;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
384;19700175143;Pharmacognosy Reviews;journal;09737847, 09762787;0.355;Q3;36;23;70;1716;101;70;1.44;74.61;India;Medknow Publications;2009-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
385;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.353;Q3;45;59;169;1229;175;142;1.07;20.83;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
386;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.35;Q3;30;29;79;893;62;79;0.75;30.79;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
387;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.347;Q2;19;13;9;538;10;8;1.25;41.38;United States;Springer Science + Business Media;2010-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Oncology (Q3); Physical and Theoretical Chemistry (Q3)"
388;4500151530;Personalized Medicine;journal;17410541;0.337;Q3;24;81;235;2697;245;180;1.6;33.30;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
389;19700188352;Toxins;journal;20726651;0.337;Q3;56;92;169;6322;187;167;1.12;68.72;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
390;21717;Die Pharmazie;journal;00317144;0.335;Q2;56;175;409;4648;463;408;1.11;26.56;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
391;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0.332;Q2;38;61;163;3711;130;160;0.8;60.84;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
392;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.331;Q3;26;45;126;1658;133;123;1.04;36.84;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
393;19700174987;Research Journal of Toxins;journal;18193560;0.331;Q3;2;0;2;0;4;2;2;0.00;United States;Academic Journals Inc.;2009, 2014-2016 (cancelled);"Agronomy and Crop Science (Q3); Food Science (Q3); Toxicology (Q3)"
394;19700174931;Asian Journal of Pharmaceutics;journal;1998409X, 09738398;0.33;Q1;16;37;108;846;117;99;1.18;22.86;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
395;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0.329;Q3;36;90;112;2966;165;111;1.43;32.96;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
396;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.325;Q3;41;119;339;3002;271;332;0.79;25.23;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3); Biochemistry (Q4)"
397;110097;Food and Drug Law Journal;journal;1064590X;0.322;Q3;18;25;110;4417;60;109;0.53;176.68;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
398;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.322;Q2;21;19;59;957;70;47;1.49;50.37;United States;Lumitext Publishing;2009-ongoing;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
399;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.321;Q2;35;60;137;1509;120;129;1.07;25.15;United States;Informa Healthcare;2013-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3)"
400;19700174961;BioProcess International;trade journal;15426319;0.321;Q3;20;183;291;883;161;286;0.56;4.83;United States;BioProcess International;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
401;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.32;Q2;13;13;16;349;14;13;1.08;26.85;United States;IPEC-Americas;2010-ongoing;"Pharmaceutical Science (Q2); Food Science (Q3)"
402;19700174900;International Journal of Green Pharmacy;journal;19984103, 09738258;0.319;Q2;18;62;123;1707;140;117;1.2;27.53;India;Medknow Publications;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
403;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0.318;Q1;43;117;441;3113;355;439;0.8;26.61;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3)"
404;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.318;Q3;25;64;123;1968;125;122;0.95;30.75;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
405;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0.315;Q2;33;84;169;1419;131;153;0.75;16.89;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
406;18384;Medicinal Chemistry Research;journal;10542523;0.314;Q2;38;214;227;5609;279;225;1.18;26.21;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
407;19700174978;American Journal of Pharmacy Benefits;journal;19454481;0.313;Q2;11;54;56;1250;14;42;0.33;23.15;United States;Managed Care & Healthcare Communications LLC;2010-ongoing;"Business and International Management (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Decision Sciences (miscellaneous) (Q3)"
408;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.312;Q3;25;70;116;1462;111;112;0.95;20.89;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
409;19446;American Pharmaceutical Review;journal;10998012;0.31;Q2;20;78;251;1183;118;250;0.58;15.17;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q2)
410;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.309;Q3;23;72;216;3634;121;210;0.51;50.47;United States;Current Medicine Group;2007-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
411;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.309;Q3;52;200;280;3506;316;217;1.25;17.53;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
412;20578;Journal of Food and Drug Analysis;journal;10219498;0.304;Q3;41;66;154;2296;134;154;0.69;34.79;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
413;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.302;Q2;10;22;22;693;21;22;0.95;31.50;Turkey;Marmara University;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
414;19700174969;Archives of Drug Information;journal;17535174;0.301;Q2;10;4;31;73;33;30;1.47;18.25;United States;John Wiley & Sons Inc.;2008-2011;"Complementary and Alternative Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
415;35190;Revista Espanola de Quimioterapia;journal;02143429;0.301;Q3;23;46;125;994;85;105;0.83;21.61;Spain;Sociedad Española de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
416;21811;Farmacia Hospitalaria;journal;11306343;0.298;Q3;21;95;214;1668;109;114;0.81;17.56;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
417;22357;IDrugs : the investigational drugs journal;journal;13697056;0.298;Q3;32;0;480;0;337;477;0.79;0.00;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
418;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;0.297;Q2;32;70;184;5043;135;156;0.91;72.04;United Kingdom;Taylor & Francis;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
419;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;0.296;Q2;25;409;228;11654;267;228;1.17;28.49;Nigeria;Academic Journals;2009-2011;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
420;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0.295;Q3;23;91;185;2707;94;185;0.48;29.75;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
421;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0.293;Q2;37;203;386;7077;345;376;0.59;34.86;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
422;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0.293;Q3;33;57;142;1338;142;141;0.81;23.47;United Kingdom;BioMed Central;2000-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
423;23171;Korean Journal of Pharmacognosy;journal;02533073;0.293;Q2;14;46;182;1104;92;182;0.43;24.00;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
424;21100421502;International Journal of Biomedical Nanoscience and Nanotechnology;journal;17560802, 17560799;0.292;Q2;7;11;14;615;14;14;1;55.91;United Kingdom;Inderscience Publishers;2010-2012;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
425;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.291;Q3;17;30;85;2789;112;74;1.96;92.97;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
426;19700175149;African Journal Biomedical Research;journal;11195096;0.287;Q2;15;36;84;854;54;83;0.33;23.72;Nigeria;Bioline International;2008, 2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3)"
427;130038;Letters in Drug Design and Discovery;journal;15701808;0.285;Q2;28;133;273;3677;249;272;0.94;27.65;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
428;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.285;Q3;47;0;217;0;197;207;0.86;0.00;Spain;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
429;19700188355;International Journal of Phytomedicine;journal;09750185;0.284;Q3;15;68;59;1796;51;59;0.86;26.41;United States;Advanced Research Journals;2010-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
430;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;0.283;Q2;15;58;77;2084;76;77;1.1;35.93;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
431;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.282;Q2;19;36;96;968;59;94;0.49;26.89;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
432;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0.281;Q3;27;87;224;2035;182;221;1.02;23.39;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
433;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.275;Q2;17;17;57;567;36;55;0.66;33.35;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmaceutical Science (Q2); Pharmacology (nursing) (Q2); Sports Science (Q3)"
434;19700178100;Nanotechnology, Science and Applications;journal;11778903;0.274;Q2;23;10;17;1114;23;17;1.35;111.40;New Zealand;Dove Medical Press Ltd.;2010-2012, 2014-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Bioengineering (Q4); Nanoscience and Nanotechnology (Q4)"
435;19700188360;Pharmaceutics;journal;19994923;0.274;Q2;32;49;28;3202;24;28;0.86;65.35;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;Pharmaceutical Science (Q2)
436;73430;Pharmaceutical Technology;journal;15432521;0.271;Q2;35;247;564;967;128;451;0.32;3.91;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q2); Biophysics (Q4)"
437;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.27;Q2;22;18;11;1092;22;11;2;60.67;Egypt;Hindawi Publishing Corporation;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3); Molecular Medicine (Q4)"
438;19700175040;Open Vaccine Journal;journal;18750354;0.27;Q2;9;4;37;262;16;36;0.44;65.50;United Arab Emirates;Bentham Science Publishers;2009-2013;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Immunology (Q4)"
439;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.269;Q2;19;16;32;376;31;31;0.74;23.50;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
440;21100205919;Open Drug Discovery Journal;journal;18773818;0.268;Q3;8;0;26;0;11;23;0.48;0.00;United Arab Emirates;Bentham Science Publishers;2010, 2014;Drug Discovery (Q3)
441;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.267;Q2;29;248;678;5261;413;676;0.6;21.21;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
442;19700175778;International Journal of Research in Pharmaceutical Sciences;journal;09757538;0.265;Q2;15;97;72;2188;84;72;1.17;22.56;India;JK Welfare & Pharmascope Foundation;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
443;17700155411;Research Journal of Environmental Toxicology;journal;18193420;0.265;Q3;12;39;50;1631;39;50;0.78;41.82;United States;Academic Journals Inc.;2009-2016 (cancelled);"Pollution (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
444;21810;Farmacia;journal;00148237;0.264;Q2;19;89;233;1509;146;233;0.7;16.96;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
445;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.263;Q2;26;25;60;680;31;54;0.57;27.20;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q2)
446;21100470510;Drug Research;journal;21949379, 21949387;0.262;Q3;56;125;370;2834;274;362;0.79;22.67;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
447;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0.26;Q3;38;49;86;7199;47;78;0.59;146.92;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Toxicology (Q3); Cancer Research (Q4)"
448;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.259;Q2;35;131;308;3078;285;305;0.94;23.50;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
449;23489;Chemical Speciation and Bioavailability;journal;09542299;0.259;Q4;25;30;81;1143;40;81;0.47;38.10;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
450;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.255;Q3;22;16;57;376;24;52;0.39;23.50;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
451;19700174904;Asian Journal of Pharmaceutical and Clinical Research;journal;09742441, 24553891;0.254;Q2;26;210;143;4928;128;141;0.91;23.47;India;Asian Journal of Pharmaceutical and Clinical Research;2009-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
452;15500154707;International Journal of Biological Chemistry;journal;1819155X;0.253;Q3;12;38;24;1422;26;24;1.08;37.42;Pakistan;ANSInet;2009-2016 (cancelled);"Pharmacology (Q3); Biochemistry (Q4)"
453;19200156925;Cancer Therapy;journal;15439143, 15439135;0.252;Q3;8;3;65;159;35;65;0.54;53.00;United States;Gene Therapy Press;2009-2014;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
454;19700174941;Pharmacognosy Research;journal;09748490, 09764836;0.252;Q3;25;49;79;1225;74;75;0.99;25.00;India;Medknow Publications;2010-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
455;22205;Saudi Pharmaceutical Journal;journal;13190164;0.252;Q2;36;35;102;1188;101;100;1.17;33.94;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
456;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.251;Q3;16;66;176;2134;116;155;0.79;32.33;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
457;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.25;Q3;19;43;64;871;43;45;0.96;20.26;Netherlands;Elsevier BV;2010-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
458;24097;Journal of the Indian Chemical Society;journal;00194522;0.247;Q3;31;242;593;7506;275;581;0.46;31.02;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q3); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
459;130031;Journal of Toxicologic Pathology;journal;09149198;0.246;Q4;20;34;87;957;37;87;0.42;28.15;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
460;20065;BioPharm International;journal;1542166X;0.244;Q2;25;116;310;624;120;277;0.39;5.38;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
461;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.24;Q3;8;0;15;0;4;13;0;0.00;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q4)"
462;19700175060;International Journal of PharmTech Research;journal;24559563, 09744304;0.239;Q3;40;322;664;6492;517;664;0.78;20.16;India;Sphinx Knowledge House;2009-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q3)"
463;4000151703;Core Evidence;journal;15551741, 1555175X;0.237;Q3;19;7;49;314;62;47;1.97;44.86;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
464;19700174933;Journal of Pharmaceutical Sciences and Research;journal;09751459;0.237;Q3;20;109;191;2717;167;191;0.87;24.93;India;PharmaInfo Publications;2009-ongoing;Pharmaceutical Science (Q3)
465;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.235;Q3;24;35;96;1097;61;95;0.4;31.34;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
466;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0.233;Q3;15;41;116;1208;30;112;0.26;29.46;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
467;11100153314;Frontiers in Medicinal Chemistry;book series;15740889;0.233;Q4;6;0;44;0;13;42;0.31;0.00;United Arab Emirates;Bentham Science Publishers;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
468;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;19430868, 1943085X;0.232;Q3;11;30;16;1108;11;15;0.73;36.93;United States;Taylor and Francis;2009-2012;"Biomedical Engineering (Q3); Pharmaceutical Science (Q3); Nanoscience and Nanotechnology (Q4)"
469;19500156813;Procedia in Vaccinology;journal;1877282X;0.228;Q3;10;43;67;1342;36;66;0.55;31.21;Netherlands;Elsevier BV;2009-2012;"Infectious Diseases (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Immunology (Q4)"
470;19700175244;Current Radiopharmaceuticals;journal;18744710;0.226;Q3;21;40;54;2644;34;49;0.69;66.10;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
471;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0.226;Q3;10;23;82;370;34;82;0.14;16.09;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
472;21265;Drugs of the Future;journal;03778282;0.221;Q3;40;105;348;6120;195;341;0.59;58.29;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
473;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0.22;Q3;34;44;76;1135;47;75;0.49;25.80;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
474;22854;Yakugaku Zasshi;journal;00316903;0.22;Q3;37;241;634;5521;344;581;0.48;22.91;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
475;15842;Journal of Applied Research;journal;1537064X;0.219;Q3;18;11;61;348;31;57;0.29;31.64;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
476;19700180522;Molecular and Cellular Toxicology;journal;1738642X;0.218;Q2;18;50;54;1451;50;50;1;29.02;Germany;Springer Verlag;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
477;79053;Natural Product Sciences;journal;12263907;0.218;Q4;22;64;140;1449;53;140;0.25;22.64;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
478;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.216;Q4;6;5;8;94;6;8;0.75;18.80;India;Medicinal and Aromatic Plants Association of India;2010-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
479;22908;Chinese Pharmacological Bulletin;journal;10011978;0.215;Q3;15;439;1225;6536;651;1225;0.59;14.89;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q3)
480;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.214;Q4;12;27;80;588;35;78;0.5;21.78;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications (Q4); Drug Discovery (Q4)"
481;19700177128;Journal of Young Pharmacists;journal;09751505, 09751483;0.212;Q2;22;56;83;1019;64;77;0.83;18.20;India;EManuscript Services;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
482;21758;Prescrire International;journal;11677422;0.209;Q3;11;207;595;1495;116;489;0.25;7.22;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
483;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0.208;Q4;18;16;68;522;25;50;0.68;32.63;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
484;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.207;Q2;17;58;179;1620;97;172;0.58;27.93;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
485;21102;Pharmaceutical Journal;journal;00316873;0.207;Q3;25;662;2969;461;59;833;0.07;0.70;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
486;21100226424;Toxicology and Environmental Health Sciences;journal;20059752;0.207;Q4;12;36;69;1190;30;69;0.43;33.06;South Korea;Korean Society of Environmental Risk Assessment and Health Science;2009-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
487;19700200821;Therapeutic delivery;journal;20415990, 20416008;0.206;Q3;37;145;70;8885;53;69;0.77;61.28;United Kingdom;Future Medicine Ltd.;2010-ongoing;Pharmaceutical Science (Q3)
488;19700201140;Systematic Reviews in Pharmacy;journal;09758453;0.205;Q3;11;17;14;1010;16;14;1.14;59.41;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q3)
489;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.198;Q3;26;71;186;3071;118;186;0.72;43.25;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Pharmacology (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
490;5800173394;Current Drug Therapy;journal;15748855;0.197;Q2;14;34;84;2889;58;81;0.62;84.97;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
491;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.197;Q3;10;0;72;0;31;70;0.3;0.00;France;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
492;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.197;Q3;11;42;85;944;20;77;0.16;22.48;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Pharmacology (Q3); Drug Discovery (Q4); Plant Science (Q4)"
493;15600154705;EnvironmentAsia;journal;19061714;0.195;Q4;14;19;77;438;30;77;0.39;23.05;Thailand;Thai Society of Higher Education Institutes on Environment;2009-ongoing;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
494;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.195;Q2;15;41;121;852;27;103;0.19;20.78;United States;SAGE Publications Inc.;2000-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
495;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.195;Q3;17;231;627;1818;49;610;0.08;7.87;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
496;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.192;Q3;8;26;33;595;17;33;0.52;22.88;Jordan;University of Jordan;2009-ongoing;Pharmaceutical Science (Q3)
497;19600162009;Advances in Molecular Toxicology;book series;18720854;0.191;Q3;10;7;23;718;12;20;0.38;102.57;Netherlands;Elsevier BV;2006, 2008-ongoing;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
498;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.191;Q2;32;95;277;2964;144;263;0.41;31.20;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
499;19408;Actualites Pharmaceutiques;journal;05153700;0.19;Q3;5;136;456;407;8;421;0.02;2.99;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
500;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.189;Q3;9;137;457;891;16;421;0.04;6.50;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (nursing) (Q3)"
501;58808;Pharmaceutical Care and Research;journal;16712838;0.189;Q3;7;158;421;1268;31;416;0.08;8.03;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
502;5200152604;Pharma Times;journal;00316849;0.189;Q2;10;56;244;254;32;180;0.14;4.54;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
503;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.189;Q3;8;58;140;1131;17;132;0.14;19.50;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
504;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876;0.188;Q3;27;30;68;903;36;68;0.53;30.10;China;Shenyang Pharmaceutical University;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
505;21800;Farmacevtski Vestnik;journal;00148229;0.188;Q3;4;49;152;815;9;139;0.08;16.63;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q3); Pharmacology (Q3)"
506;19700188319;International Journal of Pharmaceutical Sciences Review and Research;journal;0976044X;0.188;Q3;24;368;307;10323;193;304;0.63;28.05;India;Global Research Online;2010-2016 (cancelled);Pharmaceutical Science (Q3)
507;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.187;Q4;9;15;81;453;24;81;0.32;30.20;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
508;17700156303;Neuromethods;book series;19406045, 08932336;0.185;Q2;17;299;140;19806;62;127;0.49;66.24;United States;Humana Press, Inc.;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Psychiatry and Mental Health (Q3); Neuroscience (miscellaneous) (Q4)"
509;17300154738;Current Trends in Biotechnology and Pharmacy;journal;09738916;0.184;Q3;10;52;86;1430;38;86;0.44;27.50;India;Association of Biotechnology and Pharmacy;2009-ongoing;"Biotechnology (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4)"
510;22934;Chinese Pharmaceutical Journal;journal;10012494;0.183;Q3;19;456;1432;5830;232;1431;0.15;12.79;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
511;4700152607;Current Enzyme Inhibition;journal;15734080;0.183;Q4;15;25;63;2002;28;61;0.51;80.08;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
512;22375;Indian Drugs;journal;0019462X;0.183;Q3;30;94;434;1711;104;433;0.18;18.20;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
513;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.182;Q4;22;67;189;2259;98;167;0.58;33.72;United Kingdom;BioMed Central;2006-ongoing;"Infectious Diseases (Q3); Animal Science and Zoology (Q4); Parasitology (Q4); Toxicology (Q4)"
514;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685;0.18;Q3;11;17;26;511;18;26;0.69;30.06;Thailand;Chulalongkorn University;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
515;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.179;Q3;19;36;102;3401;43;92;0.58;94.47;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
516;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.176;Q3;21;0;0;0;0;0;0;0.00;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
517;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.176;Q3;5;0;5;0;2;5;0.4;0.00;Taiwan;Pharmaceutical Society of Taiwan;2007, 2009;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
518;144613;Journal of Generic Medicines;journal;17411343;0.174;Q3;14;31;122;314;55;109;0.41;10.13;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
519;21412;Zeitschrift für Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.174;Q3;12;61;200;426;25;135;0.18;6.98;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
520;73076;Drug Discovery World;journal;14694344;0.172;Q4;10;39;130;609;30;117;0.22;15.62;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
521;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.172;Q2;9;12;22;266;19;22;0.86;22.17;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
522;19700175096;Pharmacognosy Journal;journal;09753575;0.171;Q3;14;137;179;3552;86;177;0.49;25.93;India;Pharmacognosy Network Worldwide;2009-ongoing;"Pharmacology (Q3); Drug Discovery (Q4)"
523;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.17;Q4;18;121;194;1715;25;193;0.09;14.17;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
524;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.17;Q3;11;25;68;649;18;68;0.24;25.96;Turkey;Turkish Pharmacists Association;2006-ongoing;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
525;23107;Journal of Pharmacy Technology;journal;87551225;0.169;Q3;9;33;89;898;14;85;0.08;27.21;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q3)
526;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.168;Q3;35;15;36;640;27;35;0.77;42.67;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Internal Medicine (Q3); Pharmacology (Q3)"
527;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.167;Q3;3;20;67;345;7;63;0.18;17.25;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
528;21100214102;Frontiers in Pharmacology;journal;16639812;0.166;Q3;62;89;41;5867;31;41;0.76;65.92;Switzerland;Frontiers Media S.A.;2010-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
529;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0.166;Q2;14;30;78;1038;35;66;0.59;34.60;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
530;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0.165;Q3;34;27;104;689;55;101;0.43;25.52;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
531;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.165;Q3;18;16;35;598;21;33;0.64;37.38;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Pharmacology (Q3); Health Policy (Q4)"
532;19700170617;EXCLI Journal;journal;16112156;0.165;Q3;24;44;48;1448;55;47;1.17;32.91;Germany;University of Mainz;2009-ongoing;"Pharmacology (Q3); Animal Science and Zoology (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
533;80593;Journal of Medicinal Plants;journal;16840240;0.165;Q3;16;60;197;1863;53;197;0.16;31.05;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
534;17600155051;Drug Delivery Technology;trade journal;15372898;0.164;Q3;9;82;167;673;36;139;0.26;8.21;United States;Drug Delivery Technology, LLC;2009-ongoing;Pharmaceutical Science (Q3)
535;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.164;Q3;23;32;79;1322;44;75;0.67;41.31;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
536;5800179590;Pharmacologyonline;journal;18278620;0.164;Q3;21;381;875;9046;282;874;0.24;23.74;Italy;SILAE;2007-ongoing;"Pharmacology (Q3); Drug Discovery (Q4)"
537;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.164;Q3;18;145;424;2760;147;424;0.26;19.03;India;Rasayan Journal;2009-ongoing;"Chemical Engineering (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Chemistry (miscellaneous) (Q4)"
538;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;0.163;Q4;18;261;666;5447;111;666;0.17;20.87;India;Scientific Publishers;2008-ongoing;"Biochemistry (Q4); Chemistry (miscellaneous) (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
539;19700177006;Psychopharm Review;trade journal;19369255;0.163;Q3;4;12;24;518;9;24;0.38;43.17;United States;Lippincott Williams & Wilkins Ltd.;2009-2014;"Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q4)"
540;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.162;Q3;14;16;45;249;15;43;0.44;15.56;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
541;19700188318;International Journal of Advances in Pharmaceutical Sciences;journal;09761055;0.162;Q3;10;6;51;177;31;51;0.61;29.50;United States;Advanced Research Journals;2010-2011 (cancelled);"Pharmaceutical Science (Q3); Physical and Theoretical Chemistry (Q4)"
542;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.161;Q3;22;46;123;1402;59;109;0.6;30.48;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
543;19700174889;Drug Target Insights;journal;11773928;0.161;Q3;10;2;15;83;2;15;0;41.50;New Zealand;Libertas Academica;2008-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Clinical Biochemistry (Q4)"
544;19900191846;PharmacoEconomics - German Research Articles;journal;1868677X, 16123727;0.161;Q3;3;4;9;81;3;8;0.38;20.25;New Zealand;Adis Press;2010-2012;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
545;21100301409;Issues in Toxicology;book series;17577179;0.16;Q4;12;14;79;1436;38;74;0.43;102.57;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
546;21142;Pharmaceutisch Weekblad;journal;00316911;0.16;Q4;9;412;1155;674;17;803;0.02;1.64;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
547;5200152843;Farmaceutico Hospitales;journal;02144697;0.159;Q3;3;11;43;58;3;30;0.06;5.27;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
548;19700174926;International Journal of Health Research;journal;15969819, 15969886;0.159;Q4;7;22;61;438;29;59;0.49;19.91;Nigeria;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
549;22977;Journal de Pharmacie de Belgique;journal;00472166;0.159;Q3;12;28;74;356;12;70;0.19;12.71;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
550;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.158;Q3;15;37;84;815;41;84;0.48;22.03;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q3)
551;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.158;Q3;26;748;1945;9932;566;1945;0.26;13.28;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
552;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.157;Q4;18;10;66;342;32;66;0.17;34.20;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q4)
553;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.156;Q4;8;17;30;849;8;28;0.41;49.94;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Pharmacology (medical) (Q3); Infectious Diseases (Q4); Pharmacology (Q4); Virology (Q4)"
554;19700170837;Vitae;journal;01214004;0.156;Q3;11;36;67;1118;25;63;0.4;31.06;Colombia;Universidad de Antioquia;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
555;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.155;Q4;13;66;309;960;43;308;0.05;14.55;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
556;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.154;Q3;12;35;29;895;6;25;0.24;25.57;United Kingdom;John Wiley and Sons Ltd;2010-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
557;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.154;Q4;26;94;15;1210;8;10;0.8;12.87;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
558;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.154;Q3;5;37;126;291;17;119;0.15;7.86;United States;Russell Publishing LLC;2010-ongoing;"Pharmaceutical Science (Q3); Health Policy (Q4)"
559;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.154;Q3;9;28;120;489;20;113;0.16;17.46;Netherlands;IOS Press;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
560;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.153;Q3;12;18;15;436;8;10;0.8;24.22;United Kingdom;BioMed Central;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
561;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.153;Q4;26;47;9;3138;5;9;0.56;66.77;Egypt;Hindawi Publishing Corporation;2010-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
562;19700201201;EPMA Journal;journal;18785077, 18785085;0.152;Q4;26;50;57;2820;48;52;0.92;56.40;United Kingdom;BioMed Central;2010-ongoing;"Biochemistry (medical) (Q4); Drug Discovery (Q4); Health Policy (Q4)"
563;13718;Pharmaceutical Engineering;journal;02738139;0.152;Q3;13;61;125;290;18;113;0.2;4.75;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
564;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.151;Q3;14;54;114;1677;27;113;0.17;31.06;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q3)
565;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0.149;Q4;18;173;320;496;62;267;0.26;2.87;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
566;19700175125;Internet Journal of Pharmacology;journal;15312976;0.148;Q4;7;6;65;108;24;65;0.37;18.00;United States;Internet Scientific Publications;2009-2011;Pharmacology (Q4)
567;22906;Journal of China Pharmaceutical University;journal;10005048;0.147;Q3;13;109;300;1747;60;299;0.16;16.03;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
568;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.147;Q4;26;170;444;2688;127;440;0.26;15.81;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
569;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.147;Q4;22;11;20;1128;9;20;0.45;102.55;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
570;19700200880;Botulinum Journal;journal;17547326;0.146;Q3;5;7;16;186;3;14;0.21;26.57;Switzerland;Inderscience Publishers;2009-2013, 2016-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
571;19700175137;Trends in Medical Research;journal;18193587;0.146;Q3;8;14;25;428;18;25;1.07;30.57;United States;Academic Journals Inc.;2008-2016 (cancelled);"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
572;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0.145;Q4;13;141;460;2721;44;460;0.08;19.30;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
573;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;0.145;Q4;5;7;13;211;4;12;0.33;30.14;United Arab Emirates;Bentham Science Publishers;2009-2012;"Pharmacology (medical) (Q3); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
574;144879;Toxicology International;journal;09716580;0.145;Q4;21;37;54;750;29;54;0.57;20.27;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
575;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.144;Q3;6;6;37;204;12;37;0.2;34.00;Turkey;Hacettepe Universitesi;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
576;19700175858;Journal of Pharmacognosy and Phytotherapy;journal;21412502;0.143;Q4;18;20;17;818;14;17;0.82;40.90;Nigeria;Academic Journals;2010-2016 (cancelled);Drug Discovery (Q4)
577;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences;journal;09758585;0.143;Q3;24;471;296;9512;95;296;0.32;20.20;India;RJPBCS;2010-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
578;19700175120;Journal of Pharmaceutical Research and Health Care;journal;09753648;0.142;Q3;7;9;48;175;19;44;0.43;19.44;India;Medknow Publications;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
579;21795;Farmaceuticky Obzor;journal;00148172;0.141;Q3;7;37;91;812;5;85;0.07;21.95;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q3)
580;19700174997;ONdrugDelivery;trade journal;2049145X;0.141;Q3;5;47;40;219;10;38;0.26;4.66;United Kingdom;Frederick Furness Publishing;2009-ongoing;Pharmaceutical Science (Q3)
581;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.14;Q4;27;73;33;2451;16;33;0.48;33.58;Iran;University of Medical Sciences;2010-ongoing;"Biochemistry (Q4); Biophysics (Q4); Clinical Biochemistry (Q4); Drug Discovery (Q4); Immunology and Microbiology (miscellaneous)  (Q4)"
582;19700200708;Journal of Global Pharma Technology;journal;09758542;0.14;Q3;10;50;135;954;36;128;0.28;19.08;India;Journal of Global Pharma Technology;2010-ongoing;Pharmaceutical Science (Q3)
583;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;0.14;Q4;20;25;67;2156;21;67;0.28;86.24;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Medicine (miscellaneous) (Q3); Biochemistry (medical) (Q4); Drug Discovery (Q4); Immunology and Allergy (Q4)"
584;19978;Ars Pharmaceutica;journal;00042927, 23409894;0.139;Q3;18;22;246;432;34;245;0.12;19.64;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
585;145693;Canadian Pharmacists Journal;journal;17151635;0.139;Q3;18;109;262;1008;23;146;0.17;9.25;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
586;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.139;Q4;11;16;51;1;9;51;0.17;0.06;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
587;19200156912;EJHP Practice;journal;20303769, 17819989;0.138;Q3;5;93;221;722;29;170;0.18;7.76;Belgium;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
588;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.138;Q4;8;18;96;370;7;96;0;20.56;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
589;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.138;Q4;16;25;94;752;26;93;0.15;30.08;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q4)
590;21100212330;Drug discoveries & therapeutics;journal;1881784X, 18817831;0.137;Q3;19;50;52;1795;17;52;0.33;35.90;Japan;International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.);2012-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
591;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0.137;Q3;25;175;428;2427;56;293;0.18;13.87;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
592;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.137;Q3;7;0;24;0;3;19;0;0.00;United States;Haworth Press Inc.;2003-2008;"Pharmaceutical Science (Q3); Health Policy (Q4); Pharmacology (Q4)"
593;19700174940;SA Pharmaceutical Journal;journal;10151362;0.137;Q3;6;177;302;824;17;201;0.08;4.66;South Africa;Medpharm Publications Ltd.;2009-ongoing;Pharmaceutical Science (Q3)
594;21100197929;Toxicological Research;journal;19768257;0.136;Q4;20;40;87;1038;13;87;0.16;25.95;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
595;19700175758;International Journal of Drug Development and Research;journal;09759344;0.135;Q3;17;163;121;4182;38;121;0.31;25.66;India;International Journal of Drug Development and Research;2010-2015 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
596;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.135;Q4;5;0;11;0;2;11;0.18;0.00;Nigeria;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009;Pharmacology (Q4)
597;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0.135;Q4;15;20;110;783;36;69;0.54;39.15;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
598;130170;Phytotherapie;journal;17652847, 16248597;0.135;Q4;12;66;181;1643;31;143;0.19;24.89;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
599;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.135;Q3;20;12;26;277;10;26;0.38;23.08;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
600;19700182785;Ethiopian Pharmaceutical Journal;journal;10295933;0.134;Q3;3;0;15;0;5;15;0.33;0.00;Ethiopia;Ethiopian Pharmaceutical Association;2009;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
601;10900153328;Frontiers in Drug Design and Discovery;book series;15672042;0.134;Q3;8;0;17;0;8;16;0.5;0.00;United Arab Emirates;Bentham Science Publishers;2006-2009;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
602;11200153304;Future HIV Therapy;journal;17469600;0.134;Q4;8;0;57;0;32;46;0;0.00;United Kingdom;Future Medicine Ltd.;2008-2009;"Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
603;22514;Japanese Journal of Chemotherapy;journal;13407007;0.134;Q4;12;40;127;705;36;127;0.16;17.63;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
604;19700201404;Open Drug Safety Journal;journal;18768180;0.134;Q3;3;9;1;289;1;1;1;32.11;Netherlands;Bentham Science Publishers B.V.;2010-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
605;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.133;Q3;13;576;858;8648;132;858;0.13;15.01;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
606;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0.133;Q4;7;100;223;2120;17;223;0.08;21.20;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Medicine (miscellaneous) (Q3); Biochemistry (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
607;22338;Hospital Pharmacy;journal;00185787;0.133;Q4;21;151;423;2082;61;351;0.16;13.79;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacy (Q2); Pharmacology (Q4); Pharmacology (medical) (Q4)"
608;25253;Blutalkohol;journal;00065250;0.132;Q4;13;43;100;515;6;92;0.08;11.98;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
609;21100244805;Journal of Vaccines and Vaccination;journal;21577560;0.132;Q4;9;12;12;298;9;12;0.75;24.83;India;OMICS Publishing Group;2010-2014 (cancelled);"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
610;19700174645;Journal of International Pharmaceutical Research;journal;16740440;0.131;Q3;8;60;51;1442;30;47;0.64;24.03;India;Journal of International Pharmaceutical Research;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmaceutical Science (Q4)"
611;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0.13;Q4;8;0;79;0;26;79;0.33;0.00;India;R R College of Pharmacy;2010, 2012-2013;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
612;21100201517;RSC Drug Discovery Series;book series;20413203;0.13;Q4;7;0;12;0;1;11;0.09;0.00;United Kingdom;Royal Society of Chemistry;2010, 2014-ongoing;Drug Discovery (Q4)
613;19700181240;Global Journal of Pharmacology;journal;19920075;0.129;Q3;13;23;24;628;12;24;0.5;27.30;Pakistan;International Digital Organization for Scientific Information (IDOSI);2010-2014 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
614;19700174658;Regulatory Rapporteur;trade journal;17428955;0.129;Q3;5;59;76;375;5;55;0.09;6.36;United Kingdom;The Organisation for Professionals in Regulatory Affairs;2010-ongoing;"Pharmacy (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
615;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0.128;Q4;8;28;69;744;12;69;0.15;26.57;Spain;Real Academia Nacional de Farmacia;2004-2005;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
616;19700175039;Open Toxicology Journal;journal;18743404;0.128;Q4;5;0;15;0;6;15;0.4;0.00;United Arab Emirates;Bentham Science Publishers;2009-2013;Toxicology (Q4)
617;9800153137;Trastornos Adictivos;journal;15750973;0.128;Q4;8;26;85;705;18;62;0.23;27.12;Spain;Elsevier Doyma;2007-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
618;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.127;Q4;13;119;281;2141;40;279;0.13;17.99;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
619;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277;0.127;Q4;5;15;19;170;2;17;0.12;11.33;United Kingdom;Euromed Communications Ltd;2010-2015;"Pharmacy (Q3); Pharmaceutical Science (Q4)"
620;21083;Pharmaceutical Care Espana;journal;11396202;0.127;Q4;9;32;74;522;11;60;0.24;16.31;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
621;21127;Pharmaceutical Technology Europe;journal;17537967;0.127;Q4;16;119;333;382;33;275;0.12;3.21;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q4)
622;21100431352;Proceedings of ISMA 2010 - International Conference on Noise and Vibration Engineering, including USD 2010;conference and proceedings;00002010;0.127;-;12;0;387;0;76;386;0.2;0.00;Belgium;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
623;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.126;Q4;14;33;77;3010;15;71;0.29;91.21;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
624;19700175105;Open Drug Delivery Journal;journal;18741266;0.126;Q4;5;0;11;0;4;10;0.4;0.00;United Arab Emirates;Bentham Science Publishers;2009-2010, 2014;Pharmaceutical Science (Q4)
625;19700188309;Journal of Bioanalysis and Biomedicine;journal;1948593X;0.125;Q4;9;17;23;603;6;23;0.26;35.47;India;OMICS Publishing Group;2010-2014 (cancelled);Pharmaceutical Science (Q4)
626;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.125;Q4;8;32;84;995;4;64;0.03;31.09;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
627;19700175002;Pharmaceutical Reviews;journal;19185561;0.124;Q4;4;6;51;192;15;51;0.29;32.00;India;PharmaInfo Publications;2009-2011;"Analytical Chemistry (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
628;21211;Pharmacy Education;journal;14772701, 15602214;0.124;Q4;15;39;39;705;4;39;0.1;18.08;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmacy (Q3); Education (Q4); Pharmaceutical Science (Q4)"
629;19700181241;Physiology and Pharmacology;journal;24765236, 24765244;0.124;Q4;9;57;89;1708;16;89;0.18;29.96;Iran;Neuroscience Research Center;2009-ongoing;"Pharmacology (Q4); Physiology (Q4)"
630;19700175015;Infection and Drug Resistance;journal;11786973;0.123;Q4;27;24;9;1292;2;8;0.25;53.83;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
631;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.122;Q4;7;15;70;357;9;69;0.09;23.80;Egypt;Faculty of Pharmacy, Assiut University;2008-2013;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
632;21100469670;Antibiotics;journal;20796382;0.121;Q4;20;0;1;0;0;1;0;0.00;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Biochemistry (Q4); Infectious Diseases (Q4); Microbiology (Q4); Microbiology (medical) (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
633;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.121;Q4;3;110;393;1780;17;389;0.04;16.18;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
634;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.121;Q4;90;0;1;0;0;1;0;0.00;United Kingdom;Taylor & Francis;1984-2008;"Chemistry (miscellaneous) (Q4); Food Science (Q4); Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
635;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0.121;Q4;9;45;83;1073;16;80;0.19;23.84;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
636;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.121;Q4;7;0;1;0;0;1;0;0.00;New Zealand;Dove Medical Press Ltd.;2010, 2013-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
637;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.121;Q4;25;0;1;0;0;1;0;0.00;United States;The Haworth Herbal Press;2001-2007;"Biochemistry (Q4); Pharmacology (Q4)"
638;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.12;Q4;14;47;52;936;14;45;0.31;19.91;Netherlands;Elsevier BV;2009-ongoing;"Pharmacy (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
639;9100153105;Current Topics in Pharmacology;journal;09724559;0.12;Q4;4;13;42;1102;9;42;0.23;84.77;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
640;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.12;Q4;8;43;39;996;15;39;0.38;23.16;Netherlands;IOS Press;2010-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
641;12100156823;5th PCIC Europe 2008: Petroleum and Chemical Industry Conference Europe;conference and proceedings;00002008;0.119;-;5;0;29;0;7;28;0;0.00;United States;;2008;"Chemical Engineering (miscellaneous); Electrical and Electronic Engineering; Geochemistry and Petrology; Pharmaceutical Science"
642;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.119;Q4;4;41;84;980;9;74;0.12;23.90;Czech Republic;SOLEN s.r.o.;2009-ongoing;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
643;17700156705;Modern Trends in Pharmacopsychiatry;book series;16622685;0.119;Q4;10;0;25;0;5;23;0.22;0.00;Switzerland;Karger;2009-2010, 2013-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
644;19700175034;Pharmaceutical Processing;trade journal;10499156;0.119;Q4;2;44;108;44;8;87;0.09;1.00;United States;Advantage Business Media;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
645;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.119;Q4;12;77;249;1018;51;226;0.22;13.22;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
646;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.119;Q4;22;23;71;449;15;71;0.1;19.52;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q4)
647;19700174886;Arzneimitteltherapie;journal;07236913;0.118;Q4;6;141;440;1075;15;201;0.07;7.62;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
648;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0.118;Q4;15;11;18;591;6;0;0;53.73;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
649;22358;U.S. Pharmacist;journal;01484818;0.118;Q4;7;168;409;2749;29;378;0.11;16.36;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
650;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.117;Q4;17;71;344;968;29;338;0.08;13.63;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
651;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.116;Q4;10;50;93;1145;26;84;0.31;22.90;Iran;Shahid Beheshti University of Medical Sciences;2012-ongoing;"Critical Care and Intensive Care Medicine (Q3); Cardiology and Cardiovascular Medicine (Q4); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
652;19700175049;Internet Journal of Toxicology;journal;15593916;0.116;Q4;5;3;38;111;12;38;0.32;37.00;United States;Internet Scientific Publications;2009-2011, 2013, 2015;Toxicology (Q4)
653;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.116;Q4;5;11;40;160;4;39;0.15;14.55;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
654;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.115;Q4;6;0;171;0;12;164;0.06;0.00;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q4)
655;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.115;Q4;5;0;6;0;2;6;0.33;0.00;United Arab Emirates;Bentham Science Publishers;2009-2010, 2013;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
656;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;0.115;Q4;7;20;42;410;10;42;0.1;20.50;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
657;19700181314;2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009;conference and proceedings;00002009;0.114;-;4;0;71;0;11;70;0.16;0.00;United States;;2009;"Molecular Medicine; Pharmacology"
658;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.114;Q4;11;110;216;1992;23;216;0.06;18.11;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
659;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.114;Q4;12;0;26;0;8;26;0;0.00;Germany;Springer Verlag;2006-2008;"Biotechnology (Q4); Chemistry (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
660;21716;Pharmazeutische Zeitung;journal;00317136;0.114;Q4;7;524;1449;782;6;753;0.01;1.49;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
661;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.113;Q4;6;44;39;2873;9;39;0.23;65.30;New Zealand;Libertas Academica;2010-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
662;20572;PZ Prisma;journal;09455566;0.113;Q4;5;36;93;645;6;80;0.08;17.92;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
663;19700174924;Biomedical and Pharmacology Journal;journal;09746242, 24562610;0.112;Q4;12;60;167;1289;4;167;0.02;21.48;India;Oriental Scientific Pub. Co.;2009-ongoing;Pharmacology (Q4)
664;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.112;Q4;4;26;143;875;7;139;0.07;33.65;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
665;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;0.112;Q4;6;0;22;0;4;21;0;0.00;United States;Humana Press, Inc.;2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
666;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.111;Q4;2;24;94;181;2;83;0.02;7.54;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
667;21100201952;Arsenic in Geosphere and Human Diseases, As 2010 - 3rd International Congress: Arsenic in the Environment;conference and proceedings;00002010;0.111;-;4;0;234;0;8;229;0.03;0.00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
668;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.111;Q4;14;24;72;823;3;72;0;34.29;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
669;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.111;Q4;11;12;3;0;0;2;0;0.00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
670;23009;Journal of Clinical Research;journal;13695207;0.111;Q4;11;0;4;0;1;4;0;0.00;United Kingdom;Brookwood Medical Publications Ltd;1998-2009;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
671;13000154717;Current Topics in Toxicology;journal;09728228;0.11;Q4;6;13;9;542;2;9;0.4;41.69;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
672;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.11;Q4;5;63;192;479;5;192;0.03;7.60;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
673;21798;Farmaceutski Glasnik;journal;00148202;0.11;Q4;5;64;221;729;2;179;0.02;11.39;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
674;19700200860;International Journal of Current Pharmaceutical Review and Research;journal;0976822X;0.109;Q4;9;19;13;529;2;13;0.15;27.84;India;Publishers, In-IJCPR;2010-2016 (cancelled);Pharmaceutical Science (Q4)
675;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.108;Q4;3;77;138;96;4;137;0.03;1.25;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
676;19700175099;Topics in Medicinal Chemistry;book series;18622461;0.108;Q4;8;8;25;1218;2;19;0.11;152.25;Germany;Springer Verlag;2009-ongoing;"Drug Discovery (Q4); Molecular Medicine (Q4)"
677;22887;Chinese Journal of Antibiotics;journal;10018689;0.107;Q4;10;174;526;2441;43;525;0.06;14.03;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
678;20628;Circular Farmaceutica;journal;00097314;0.107;Q4;2;29;110;391;1;97;0.02;13.48;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
679;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.107;Q4;9;32;34;710;4;34;0.12;22.19;Iran;Shiraz University of Medical Sciences;2010-ongoing;"Bioengineering (Q4); Pharmaceutical Science (Q4)"
680;22979;Journal of Applied Therapeutic Research;journal;10292659;0.107;Q4;7;12;30;238;3;30;0.06;19.83;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
681;13637;Manufacturing Chemist;journal;02624230;0.107;Q4;6;103;262;216;4;243;0.01;2.10;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
682;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.107;Q4;5;13;46;394;5;38;0.21;30.31;Switzerland;Springer International Publishing AG;2007-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
683;25197;Revista de Toxicologia;journal;16970748, 02127113;0.107;Q4;9;12;38;460;5;37;0.12;38.33;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
684;19430;Adverse Drug Reaction Bulletin;journal;00446394;0.106;Q4;7;6;16;221;3;16;0.2;36.83;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
685;19700174922;Chinese Journal of New Drugs;journal;10033734;0.106;Q4;9;537;1269;7299;75;1269;0.05;13.59;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
686;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.106;Q4;9;41;162;645;11;162;0.08;15.73;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
687;21100804474;European Pharmaceutical Journal;journal;24536725;0.106;Q4;5;10;33;213;3;31;0.1;21.30;Germany;de Gruyter;2016-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
688;21867;Geneesmiddelenbulletin;journal;03044629;0.106;Q4;6;66;163;302;3;64;0.05;4.58;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
689;5800207507;Side Effects of Drugs Annual;book series;03786080;0.106;Q4;5;52;156;5408;4;103;0.02;104.00;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
690;19399;Acta Pharmaceutica Hungarica;journal;00016659;0.105;Q4;12;18;51;706;7;51;0.12;39.22;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
691;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.105;Q4;4;104;326;1654;10;326;0.03;15.90;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
692;4000151610;International Journal of Neuroprotection and Neurogeneration;journal;17451183, 17451191;0.105;Q4;5;0;11;0;2;9;0;0.00;United Kingdom;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
693;25196;Revista Brasileira de Toxicologia;journal;14152983;0.105;Q4;6;0;25;0;3;25;0.08;0.00;Brazil;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
694;21100229846;2010 International Symposium on Waterborne Pathogens;conference and proceedings;00002010;0.104;-;1;0;33;0;1;32;0.03;0.00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
695;19700175108;Drug Delivery System;journal;09135006;0.104;Q4;7;29;87;541;6;87;0.02;18.66;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
696;19700174925;European Pharmaceutical Review;trade journal;13608606;0.104;Q4;7;30;72;542;5;64;0.08;18.07;United Kingdom;Russell Publishing Ltd;2009-ongoing;"Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
697;21823;Farmatsija;journal;04280296;0.104;Q4;5;15;27;295;3;27;0;19.67;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
698;19700172219;ISB 2010 Proceedings - International Symposium on Biocomputing;conference and proceedings;00002010;0.104;-;4;0;50;0;5;48;0.1;0.00;United States;;2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Computational Theory and Mathematics; Pharmaceutical Science; Software"
699;19700201410;Milestones in Drug Therapy;book series;22966056;0.104;Q4;4;18;41;1246;2;41;0.05;69.22;United States;Springer Science + Business Media;2010-ongoing;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
700;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.104;Q4;17;0;10;0;1;8;0;0.00;United Kingdom;Librapharm Ltd.;1997-2008;"Pediatrics, Perinatology and Child Health (Q4); Pharmacology (Q4)"
701;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.104;Q4;9;29;85;265;3;83;0.02;9.14;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q4)
702;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.103;Q4;4;19;56;402;5;49;0.09;21.16;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
703;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.103;Q4;8;0;7;0;2;7;0.29;0.00;India;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007;Pharmacology (Q4)
704;21243;Pharmacy times;trade journal;00030627;0.103;Q4;8;187;584;1027;15;518;0.03;5.49;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
705;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.103;Q4;2;0;7;0;0;7;0;0.00;Germany;Wissenschaftliche Verlagsgesellschaft;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
706;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.103;Q4;37;0;6;0;0;6;0;0.00;United States;PJD Publications Ltd.;1994-2007, 2009;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
707;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.102;Q4;5;25;16;471;3;12;0.25;18.84;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
708;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.102;Q4;12;31;63;772;3;63;0.05;24.90;Iran;Tabriz University of Medical Sciences;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
709;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;0.102;Q4;2;3;12;103;0;12;0;34.33;Russian Federation;SRL Archive;2009-2012;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
710;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.101;Q4;6;36;107;0;3;107;0;0.00;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
711;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0.101;Q4;9;8;26;89;2;21;0.08;11.13;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
712;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.101;Q4;9;0;65;0;1;65;0;0.00;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
713;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.101;Q4;2;0;25;0;0;22;0;0.00;Japan;Research Laboratory of Shionogi and Co.;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
714;19700171709;Arhiv za Farmaciju;journal;00041963, 22178767;0.101;Q4;3;31;71;841;1;70;0.01;27.13;Serbia;Farmaceutsko Drustvo Srbije;1954-1955, 2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
715;21100229867;AWWA 2010 Inorganic Contaminants Workshop;conference and proceedings;00002010;0.101;-;1;0;29;0;0;28;0;0.00;United States;;2010;"Health, Toxicology and Mutagenesis; Toxicology"
716;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;12;0;20;0;0;18;0;0.00;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
717;21238;Drug Topics;journal;00126616;0.101;Q4;7;294;656;283;3;319;0.01;0.96;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
718;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.101;Q4;3;65;189;269;3;185;0.01;4.14;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
719;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;0.101;Q4;3;19;84;276;1;72;0.02;14.53;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology (Q4); Pharmacology (Q4)"
720;19500157008;Fooyin Journal of Health Sciences;journal;18778607;0.101;Q4;5;0;35;0;5;33;0.15;0.00;Netherlands;Elsevier BV;2009-2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
721;15680;Giornale di Neuropsicofarmacologia;journal;03919048;0.101;Q4;1;0;18;0;0;16;0;0.00;Italy;C I C Edizioni International srl;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
722;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0.101;Q4;7;101;317;780;3;305;0.01;7.72;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
723;19700201516;Journal of Chemical and Pharmaceutical Sciences;journal;09742115;0.101;Q4;11;41;69;542;2;69;0.03;13.22;India;SPB Pharma Society;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
724;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.101;Q4;5;261;693;3593;13;693;0.01;13.77;China;Jilin University;2005-ongoing;Pharmacology (Q4)
725;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.101;Q4;7;0;23;0;0;23;0;0.00;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
726;21077;Pharmaca;journal;00316857;0.101;Q4;4;19;44;258;3;34;0.09;13.58;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
727;20543;Pharmacometrics;journal;03008533;0.101;Q4;6;16;39;219;1;39;0.03;13.69;Japan;Japanese Society or Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
728;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;1;23;23;53;0;18;0;2.30;United Kingdom;Euromed Communications Ltd;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
729;19700174966;Pharmakeftiki;journal;11054999;0.101;Q4;2;0;32;0;0;30;0;0.00;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
730;72755;Phytomedica;journal;09723293;0.101;Q4;4;0;14;0;0;14;0;0.00;India;Scientific Publishers;1999-2006;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
731;17716;Quality Assurance Journal;journal;10991786, 10878378;0.101;Q4;7;13;32;163;5;29;0.17;12.54;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
732;16800154712;Sp2;trade journal;1476184X;0.101;Q4;1;51;138;28;1;124;0.01;0.55;United Kingdom;Manor Creative;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
733;19800188037;2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010;conference and proceedings;00002010;0.1;-;4;0;54;0;3;51;0.06;0.00;United States;;2010;"Molecular Medicine; Pharmacology"
734;19700182251;Air and Waste Management Association - Harmonizing Greenhouse Gas Assessment and Reporting Processes 2009;conference and proceedings;00002009;0.1;-;0;0;44;0;0;42;0;0.00;United States;;2009;"Ecology; Pollution; Toxicology; Waste Management and Disposal"
735;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;2;19;54;254;2;54;0.04;13.37;Azerbaijan;Azarbaucan Tibb Universiteti;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
736;19700173109;Contract Pharma;trade journal;15443469;0.1;Q4;3;157;249;264;2;200;0.01;1.68;United States;Contract Pharma;2009-ongoing;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
737;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;42;139;35;1;117;0.02;0.83;Germany;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
738;19700174996;European Life Science Journal;trade journal;20001444;0.1;Q4;1;16;121;0;0;119;0;0.00;Thailand;The Psychiatric Association of Thailand;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
739;19700174923;Farmaceutyczny Przeglad Naukowy;journal;14255073;0.1;Q4;3;14;85;376;2;84;0.02;26.86;Poland;Medical University of Silesia;2010-2011;Pharmaceutical Science (Q4)
740;19700169211;Life Science Clusters;trade journal;17528119;0.1;Q4;0;0;71;0;0;65;0;0.00;United Kingdom;Avakado Limited;2009-2010;"Biotechnology (Q4); Industrial Relations (Q4); Management of Technology and Innovation (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
741;19700175602;Next Generation Pharmaceutical;trade journal;-;0.1;Q4;1;31;190;0;0;132;0;0.00;United Kingdom;GDS International;2009-2011;"Drug Discovery (Q4); Marketing (Q4); Organizational Behavior and Human Resource Management (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Strategy and Management (Q4)"
742;19700174975;Pharmaceutical Formulation and Quality;trade journal;15312135;0.1;Q4;1;40;49;329;0;43;0;8.23;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-2012;Pharmaceutical Science (Q4)
743;21227;Pharmacy in Practice;journal;13581538;0.1;Q4;5;0;79;0;1;67;0;0.00;United Kingdom;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
744;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;123;514;8;0;206;0;0.07;Spain;Reed Business Information Ltd;2006-2011;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
745;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0.1;Q4;12;55;192;699;0;191;0;12.71;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
746;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;;-;23;14;0;404;0;0;0;28.86;Iran;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
747;19700188326;American Journal of Drug Discovery and Development;journal;2150427X, 21504296;;-;9;18;0;701;0;0;0;38.94;United States;Academic Journals Inc.;2011-2016 (cancelled);Drug Discovery
748;21000195625;Asian Journal of Pharmaceutical Research and Health Care;journal;22501444, 22501460;;-;4;10;0;122;0;0;0;12.20;India;Journal of Pharmaceutical Research and Health Care;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
749;21100238633;BioImpacts;journal;22285652, 22285660;;-;24;35;0;1052;0;0;0;30.06;Iran;Tabriz University of Medical Sciences;2011-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmaceutical Science"
750;21100788810;Chemotherapy Research and Practice;journal;20902115, 20902107;;-;5;1;0;116;0;0;0;116.00;United States;Hindawi Limited;2011, 2014-2015;"Oncology; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
751;19700200724;Der Pharmacia Lettre;journal;09755071;;-;24;280;0;5330;0;0;0;19.04;United States;Scholars Research Library;2011-2016 (cancelled);Pharmaceutical Science
752;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;;-;27;46;0;1758;0;0;0;38.22;Germany;Springer verlag;2011-ongoing;Pharmaceutical Science
753;21100195303;Eurasian Journal of Analytical Chemistry;journal;13063057;;-;8;21;1;525;0;1;0;25.00;Turkey;Moment Publications;2011-ongoing;"Analytical Chemistry; Electrochemistry; Pharmaceutical Science; Spectroscopy"
754;19900194805;Genomic Medicine, Biomarkers, and Health Sciences;journal;22114254;;-;5;19;0;679;0;0;0;35.74;Taiwan;Elsevier Taiwan;2011-2012;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Biomedical Engineering; Drug Discovery; Medicine (miscellaneous)"
755;21100202747;GMP Review;trade journal;14764547;;-;2;17;0;46;0;0;0;2.71;United Kingdom;Euromed Communications Ltd;2011-2015;Pharmaceutical Science
756;21100199794;Industrial Pharmacy;trade journal;17414911;;-;4;19;0;93;0;0;0;4.89;United Kingdom;Euromed Communications Ltd;2011-ongoing;Pharmaceutical Science
757;21100265336;International Arabic Journal of Antimicrobial Agents;journal;21749094;;-;6;6;0;175;0;0;0;29.17;United Kingdom;Internet Medical Publishing;2011-2015;"Microbiology (medical); Pharmacology; Pharmacology (medical)"
758;19900192735;International Drug Discovery;journal;21504806, 21504792;;-;4;28;0;735;0;0;0;26.25;United States;Russell Publishing LLC;2011-2012;Drug Discovery
759;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;;-;27;4;0;327;0;0;0;81.75;Netherlands;Elsevier BV;2011-ongoing;"Infectious Diseases; Parasitology; Pharmacology; Pharmacology (medical)"
760;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;;-;9;14;0;451;0;0;0;32.21;India;International Journal of Applied Pharmaceutics;2011-ongoing;Pharmaceutical Science
761;19900193266;International Journal of Ayurveda Research;journal;0974925X, 09747788;;-;6;19;0;236;0;0;0;12.42;India;Medknow Publications;2011;Pharmaceutical Science
762;19700201333;International Journal of Drug Delivery;journal;09750215;;-;11;75;0;2326;0;0;0;31.01;United States;Advanced Research Journals;2011-2016 (cancelled);Pharmaceutical Science
763;20500195212;International Journal of Drug Delivery Technology;journal;09754415;;-;7;17;0;682;0;0;0;40.12;Australia;International Journal of Drug Delivery Technology;2011-ongoing;Pharmaceutical Science
764;21100785531;International Journal of Medicinal and Aromatic Plants;journal;22494340;;-;2;1;0;19;0;0;0;19.00;India;Open Access Science Research Publisher;2013;"Drug Discovery; Plant Science"
765;19900192173;International Journal of Pharmaceutical and Clinical Research;journal;09751556;;-;9;18;0;394;0;0;0;21.89;Australia;International Journal of Pharmaceutical and Clinical Research;2011-2016 (cancelled);"Drug Discovery; Pharmaceutical Science; Pharmacology (medical)"
766;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;;-;5;2;0;33;0;0;0;16.50;India;In-IJPQA;2011, 2013-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
767;20400195018;International Journal of Pharmacognosy and Phytochemical Research;journal;09754873;;-;14;23;0;388;0;0;0;16.87;India;International Journal of Pharmacognosy and Phytochemical Research;2011-2016 (cancelled);Drug Discovery
768;19700201471;International Journal of Pharmacy and Technology;journal;0975766X;;-;15;240;0;6273;0;0;0;26.14;India;International Journal of Pharmacy and Technology(IJPT);2011-2016 (cancelled);"Biomedical Engineering; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
769;21100205709;International Journal of Toxicological and Pharmacological Research;journal;09755160;;-;8;6;0;176;0;0;0;29.33;Australia;International Journal of Toxicological and Pharmacological Research;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
770;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;;-;28;326;0;8387;0;0;0;25.73;India;MediPoeia;2011-ongoing;"Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
771;19700188484;Journal of Bioequivalence and Bioavailability;journal;09750851;;-;10;58;0;1352;0;0;0;23.31;India;OMICS Publishing Group;2011-2014 (cancelled);Pharmaceutical Science
772;19700201521;Journal of Chemical and Pharmaceutical Research;journal;09757384;;-;29;634;0;14513;0;0;0;22.89;India;JOCPR;2011-2014 (cancelled);Pharmaceutical Science
773;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;;-;10;81;0;1807;0;0;0;22.31;China;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-ongoing;Pharmaceutical Science
774;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;;-;21;30;0;738;0;0;0;24.60;China;Xi'an Jiaotong University;2014-ongoing;"Analytical Chemistry; Drug Discovery; Electrochemistry; Pharmaceutical Science; Pharmacy; Spectroscopy"
775;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;;-;27;89;0;3272;0;0;0;36.76;India;Medknow Publications and Media Pvt. Ltd;2011-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Bioengineering; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
776;21100237602;Journal of Pharmacy and Nutrition Sciences;journal;19275951, 22233806;;-;8;27;0;811;0;0;0;30.04;Canada;Lifescience Global;2011-ongoing;"Health (social science); Medicine (miscellaneous); Nutrition and Dietetics; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
777;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;;-;6;28;0;282;0;0;0;10.07;India;Punjab Academy of Forensic Medicine and Toxicology;2011-ongoing;"Pathology and Forensic Medicine; Toxicology"
778;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;;-;15;7;0;160;0;0;0;22.86;Netherlands;Kowsar Publishing Company;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
779;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;330;424;4699;169;424;0.33;14.24;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
780;21100301603;National Journal of Physiology, Pharmacy and Pharmacology;journal;23204672;;-;7;16;0;296;0;0;0;18.50;India;Mrs Dipika Charan for MedScience Publishers;2011-2017 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Physiology"
781;21100451405;Natural Products Journal;journal;22103163, 22103155;;-;9;18;0;728;0;0;0;40.44;Netherlands;Bentham Science Publishers B.V.;2011-ongoing;"Complementary and Alternative Medicine; Drug Discovery"
782;19700201609;Open Natural Products Journal;journal;18748481;;-;3;3;0;142;0;0;0;47.33;Netherlands;Bentham Science Publishers B.V.;2011-2014;"Complementary and Alternative Medicine; Drug Discovery"
783;19900193894;Open Pharmacoeconomics and Health Economics Journal;journal;18768245;;-;3;2;0;38;0;0;0;19.00;Netherlands;Bentham Science Publishers B.V.;2011-2013;"Economics, Econometrics and Finance (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
784;21100196907;Open Toxinology Journal;journal;18754147;;-;2;1;0;60;0;0;0;60.00;United Arab Emirates;Bentham Science Publishers;2011-2013;"Health, Toxicology and Mutagenesis; Pharmacology (medical); Toxicology"
785;19700201509;Pharma Research;journal;09758216;;-;4;46;0;1208;0;0;0;26.26;India;Sudarshan Publications;2011-2016 (cancelled);"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
786;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;;-;14;399;0;8587;0;0;0;21.52;India;A and V Publication;2011-ongoing;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
787;19900192163;Results in Pharma Sciences;journal;22112863;;-;13;11;0;385;0;0;0;35.00;Netherlands;Elsevier BV;2011-ongoing;Pharmaceutical Science
788;19700194018;Russian Journal of Biopharmaceuticals;journal;20738099;;-;4;35;0;814;0;0;0;23.26;Russian Federation;Folium Publishing Company;2011-ongoing;"Bioengineering; Drug Discovery"
789;21100199811;Stamford Journal of Pharmaceutical Sciences;journal;19997108;;-;7;26;0;469;0;0;0;18.04;Bangladesh;Department of Pharmacy, Stamford University Bangladesh;2011;Pharmaceutical Science
790;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;;-;11;50;0;1311;0;0;0;26.22;United Kingdom;Taylor and Francis Inc.;2011-ongoing;"Pharmaceutical Science; Statistics and Probability"
791;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;15830012;;-;3;62;0;1137;0;0;0;18.34;Romania;Rp Publishing House;2011-2012, 2014-ongoing;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
792;21100376682;Toxicologie Analytique et Clinique;journal;23520078;;-;5;31;0;667;0;0;0;21.52;Italy;Elsevier Masson SAS;2014-ongoing;"Health, Toxicology and Mutagenesis; Toxicology"
